PT1183256E - Derivados de purina, processo de preparação e composições farmacêuticas que os contêm - Google Patents
Derivados de purina, processo de preparação e composições farmacêuticas que os contêm Download PDFInfo
- Publication number
- PT1183256E PT1183256E PT00929625T PT00929625T PT1183256E PT 1183256 E PT1183256 E PT 1183256E PT 00929625 T PT00929625 T PT 00929625T PT 00929625 T PT00929625 T PT 00929625T PT 1183256 E PT1183256 E PT 1183256E
- Authority
- PT
- Portugal
- Prior art keywords
- amino
- cyclopentyl
- formula
- trans
- aminocyclohexyl
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims description 15
- 238000002360 preparation method Methods 0.000 title claims description 7
- 229940083251 peripheral vasodilators purine derivative Drugs 0.000 title description 5
- 125000000561 purinyl group Chemical class N1=C(N=C2N=CNC2=C1)* 0.000 title 1
- -1 phenyl radicals Chemical class 0.000 claims description 292
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 243
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 101
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 68
- 238000000034 method Methods 0.000 claims description 61
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 54
- 150000003254 radicals Chemical class 0.000 claims description 54
- 125000004432 carbon atom Chemical group C* 0.000 claims description 50
- 238000006243 chemical reaction Methods 0.000 claims description 46
- 150000001875 compounds Chemical class 0.000 claims description 35
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 31
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 25
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 22
- 239000011707 mineral Substances 0.000 claims description 22
- 239000002253 acid Substances 0.000 claims description 20
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 20
- 125000000217 alkyl group Chemical group 0.000 claims description 19
- 125000005843 halogen group Chemical group 0.000 claims description 18
- 239000003814 drug Substances 0.000 claims description 17
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 claims description 17
- 125000003545 alkoxy group Chemical group 0.000 claims description 16
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 16
- 125000006239 protecting group Chemical group 0.000 claims description 16
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 16
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 13
- 150000003839 salts Chemical class 0.000 claims description 13
- 125000003118 aryl group Chemical group 0.000 claims description 11
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 10
- 150000007522 mineralic acids Chemical class 0.000 claims description 10
- 150000007524 organic acids Chemical class 0.000 claims description 10
- 150000007530 organic bases Chemical class 0.000 claims description 9
- ORTFAQDWJHRMNX-UHFFFAOYSA-M oxidooxomethyl Chemical compound [O-][C]=O ORTFAQDWJHRMNX-UHFFFAOYSA-M 0.000 claims description 9
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 9
- 125000003831 tetrazolyl group Chemical group 0.000 claims description 9
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims description 8
- 206010028980 Neoplasm Diseases 0.000 claims description 7
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 7
- 235000005985 organic acids Nutrition 0.000 claims description 7
- 238000007254 oxidation reaction Methods 0.000 claims description 7
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 claims description 7
- 208000024827 Alzheimer disease Diseases 0.000 claims description 6
- 201000004681 Psoriasis Diseases 0.000 claims description 6
- YUDRVAHLXDBKSR-UHFFFAOYSA-N [CH]1CCCCC1 Chemical compound [CH]1CCCCC1 YUDRVAHLXDBKSR-UHFFFAOYSA-N 0.000 claims description 6
- 125000003158 alcohol group Chemical group 0.000 claims description 6
- 125000004414 alkyl thio group Chemical group 0.000 claims description 6
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 6
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims description 6
- CPHXLFKIUVVIOQ-UHFFFAOYSA-N 2-(trifluoromethoxy)benzaldehyde Chemical group FC(F)(F)OC1=CC=CC=C1C=O CPHXLFKIUVVIOQ-UHFFFAOYSA-N 0.000 claims description 5
- 239000005711 Benzoic acid Substances 0.000 claims description 5
- 241000233866 Fungi Species 0.000 claims description 5
- 150000001299 aldehydes Chemical class 0.000 claims description 5
- 230000002927 anti-mitotic effect Effects 0.000 claims description 5
- 238000002512 chemotherapy Methods 0.000 claims description 5
- 125000005982 diphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims description 5
- 150000002148 esters Chemical group 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- 238000006722 reduction reaction Methods 0.000 claims description 5
- 238000005886 esterification reaction Methods 0.000 claims description 4
- 150000002576 ketones Chemical group 0.000 claims description 4
- 150000003462 sulfoxides Chemical class 0.000 claims description 4
- PNDPNCSMYVPNAC-UFLMWKHXSA-N Cl.Cl.C1C[C@@H](N)CC[C@@H]1NC1=NC(NC=2C=CC(CC#N)=CC=2)=C(N=CN2C3CCCC3)C2=N1 Chemical compound Cl.Cl.C1C[C@@H](N)CC[C@@H]1NC1=NC(NC=2C=CC(CC#N)=CC=2)=C(N=CN2C3CCCC3)C2=N1 PNDPNCSMYVPNAC-UFLMWKHXSA-N 0.000 claims description 3
- XXJUWWSURYTSCT-HEOZJBRKSA-N Cl.Cl.COc1ccc(Nc2nc(N[C@H]3CC[C@H](N)CC3)nc3n(cnc23)C2CCCC2)cc1 Chemical compound Cl.Cl.COc1ccc(Nc2nc(N[C@H]3CC[C@H](N)CC3)nc3n(cnc23)C2CCCC2)cc1 XXJUWWSURYTSCT-HEOZJBRKSA-N 0.000 claims description 3
- 230000002555 anti-neurodegenerative effect Effects 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 125000002757 morpholinyl group Chemical group 0.000 claims description 3
- 208000015122 neurodegenerative disease Diseases 0.000 claims description 3
- 230000009223 neuronal apoptosis Effects 0.000 claims description 3
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 claims description 3
- 125000004076 pyridyl group Chemical group 0.000 claims description 3
- 238000007127 saponification reaction Methods 0.000 claims description 3
- 125000004001 thioalkyl group Chemical group 0.000 claims description 3
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 claims description 2
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims description 2
- ZPFSQNUOEIAPRQ-PVPJKCDMSA-N Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccc(cc2)N2CCOCC2)c2ncn(C3CCCC3)c2n1 Chemical compound Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccc(cc2)N2CCOCC2)c2ncn(C3CCCC3)c2n1 ZPFSQNUOEIAPRQ-PVPJKCDMSA-N 0.000 claims description 2
- 230000006909 anti-apoptosis Effects 0.000 claims description 2
- 239000003638 chemical reducing agent Substances 0.000 claims description 2
- JEVCWSUVFOYBFI-UHFFFAOYSA-N cyanyl Chemical compound N#[C] JEVCWSUVFOYBFI-UHFFFAOYSA-N 0.000 claims description 2
- 230000001537 neural effect Effects 0.000 claims description 2
- XKTYXVDYIKIYJP-UHFFFAOYSA-N 3h-dioxole Chemical compound C1OOC=C1 XKTYXVDYIKIYJP-UHFFFAOYSA-N 0.000 claims 1
- BIULRBPHIVGVNR-WKILWMFISA-N N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2cc(cc(c2)C(O)=O)C(O)=O)c2ncn(C3CCCC3)c2n1 Chemical compound N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2cc(cc(c2)C(O)=O)C(O)=O)c2ncn(C3CCCC3)c2n1 BIULRBPHIVGVNR-WKILWMFISA-N 0.000 claims 1
- RGKCQSDVAHPJRB-SAABIXHNSA-N N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccc(cc2)C#N)c2ncn(C3CCCC3)c2n1 Chemical compound N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccc(cc2)C#N)c2ncn(C3CCCC3)c2n1 RGKCQSDVAHPJRB-SAABIXHNSA-N 0.000 claims 1
- 229910006074 SO2NH2 Inorganic materials 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-M benzoate Chemical compound [O-]C(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-M 0.000 claims 1
- 125000004188 dichlorophenyl group Chemical group 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 238000003379 elimination reaction Methods 0.000 claims 1
- 150000002828 nitro derivatives Chemical class 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 239000000047 product Substances 0.000 description 545
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 390
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 370
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 302
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 276
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 260
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 185
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 172
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 152
- 239000000377 silicon dioxide Substances 0.000 description 130
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 117
- 239000003480 eluent Substances 0.000 description 112
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 110
- 238000005481 NMR spectroscopy Methods 0.000 description 110
- VKIRRGRTJUUZHS-UHFFFAOYSA-N cyclohexane-1,4-diamine Chemical compound NC1CCC(N)CC1 VKIRRGRTJUUZHS-UHFFFAOYSA-N 0.000 description 91
- 235000019439 ethyl acetate Nutrition 0.000 description 90
- 239000013078 crystal Substances 0.000 description 87
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 84
- 229910021529 ammonia Inorganic materials 0.000 description 78
- 239000002904 solvent Substances 0.000 description 76
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 74
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 65
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 62
- 239000000243 solution Substances 0.000 description 61
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 60
- 238000000746 purification Methods 0.000 description 57
- 230000002829 reductive effect Effects 0.000 description 52
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 50
- 238000004587 chromatography analysis Methods 0.000 description 39
- 238000003756 stirring Methods 0.000 description 35
- 239000000203 mixture Substances 0.000 description 30
- 229920006395 saturated elastomer Polymers 0.000 description 29
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 28
- 239000011780 sodium chloride Substances 0.000 description 25
- 239000000460 chlorine Substances 0.000 description 24
- 238000005160 1H NMR spectroscopy Methods 0.000 description 22
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 20
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 20
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 20
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 18
- 239000007864 aqueous solution Substances 0.000 description 17
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 16
- 235000010755 mineral Nutrition 0.000 description 15
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 14
- 229910000024 caesium carbonate Inorganic materials 0.000 description 14
- 230000009471 action Effects 0.000 description 12
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 12
- KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 description 11
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 11
- FAMRKDQNMBBFBR-BQYQJAHWSA-N diethyl azodicarboxylate Substances CCOC(=O)\N=N\C(=O)OCC FAMRKDQNMBBFBR-BQYQJAHWSA-N 0.000 description 11
- FAMRKDQNMBBFBR-UHFFFAOYSA-N ethyl n-ethoxycarbonyliminocarbamate Chemical compound CCOC(=O)N=NC(=O)OCC FAMRKDQNMBBFBR-UHFFFAOYSA-N 0.000 description 11
- 239000007787 solid Substances 0.000 description 11
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 11
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 10
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 10
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 10
- GIZCKBSSWNIUMZ-UHFFFAOYSA-N methyl 4-(aminomethyl)benzoate;hydrochloride Chemical compound Cl.COC(=O)C1=CC=C(CN)C=C1 GIZCKBSSWNIUMZ-UHFFFAOYSA-N 0.000 description 9
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 8
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 8
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 8
- 150000007513 acids Chemical class 0.000 description 8
- 238000009938 salting Methods 0.000 description 8
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 7
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 7
- 238000001914 filtration Methods 0.000 description 7
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 7
- 239000011734 sodium Substances 0.000 description 7
- 229910052708 sodium Inorganic materials 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 6
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 238000010561 standard procedure Methods 0.000 description 6
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 5
- IMLXLGZJLAOKJN-UHFFFAOYSA-N 4-aminocyclohexan-1-ol Chemical compound NC1CCC(O)CC1 IMLXLGZJLAOKJN-UHFFFAOYSA-N 0.000 description 5
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 5
- 108091000080 Phosphotransferase Proteins 0.000 description 5
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 239000000546 pharmaceutical excipient Substances 0.000 description 5
- 102000020233 phosphotransferase Human genes 0.000 description 5
- 229910000104 sodium hydride Inorganic materials 0.000 description 5
- 125000001424 substituent group Chemical group 0.000 description 5
- 239000003826 tablet Substances 0.000 description 5
- LQLOGZQVKUNBRX-UHFFFAOYSA-N (3-iodophenyl)methanamine Chemical compound NCC1=CC=CC(I)=C1 LQLOGZQVKUNBRX-UHFFFAOYSA-N 0.000 description 4
- PJUPKRYGDFTMTM-UHFFFAOYSA-N 1-hydroxybenzotriazole;hydrate Chemical compound O.C1=CC=C2N(O)N=NC2=C1 PJUPKRYGDFTMTM-UHFFFAOYSA-N 0.000 description 4
- XUJFOSLZQITUOI-UHFFFAOYSA-N 4-(trifluoromethoxy)aniline Chemical compound NC1=CC=C(OC(F)(F)F)C=C1 XUJFOSLZQITUOI-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 230000022131 cell cycle Effects 0.000 description 4
- 238000006482 condensation reaction Methods 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 4
- 238000002329 infrared spectrum Methods 0.000 description 4
- 230000000873 masking effect Effects 0.000 description 4
- ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- 235000011181 potassium carbonates Nutrition 0.000 description 4
- 150000003212 purines Chemical class 0.000 description 4
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- XDPCNPCKDGQBAN-UHFFFAOYSA-N 3-hydroxytetrahydrofuran Chemical compound OC1CCOC1 XDPCNPCKDGQBAN-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- FEWJPZIEWOKRBE-XIXRPRMCSA-N Mesotartaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-XIXRPRMCSA-N 0.000 description 3
- FQTWUFCUJFDNRX-MXVIHJGJSA-N N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNCc2cc(Cl)cc(Cl)c2)c2ncn(C3CCCC3)c2n1 Chemical compound N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNCc2cc(Cl)cc(Cl)c2)c2ncn(C3CCCC3)c2n1 FQTWUFCUJFDNRX-MXVIHJGJSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric Acid Chemical compound [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 3
- 125000002252 acyl group Chemical group 0.000 description 3
- 230000006907 apoptotic process Effects 0.000 description 3
- 125000004429 atom Chemical group 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- XCIXKGXIYUWCLL-UHFFFAOYSA-N cyclopentanol Chemical compound OC1CCCC1 XCIXKGXIYUWCLL-UHFFFAOYSA-N 0.000 description 3
- 150000004985 diamines Chemical class 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 125000000623 heterocyclic group Chemical group 0.000 description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- LULAYUGMBFYYEX-UHFFFAOYSA-N metachloroperbenzoic acid Natural products OC(=O)C1=CC=CC(Cl)=C1 LULAYUGMBFYYEX-UHFFFAOYSA-N 0.000 description 3
- 229940098779 methanesulfonic acid Drugs 0.000 description 3
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 3
- 150000004965 peroxy acids Chemical class 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 238000005185 salting out Methods 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- ABADUMLIAZCWJD-UHFFFAOYSA-N 1,3-dioxole Chemical compound C1OC=CO1 ABADUMLIAZCWJD-UHFFFAOYSA-N 0.000 description 2
- JDSCHBFHVKTPOP-UHFFFAOYSA-N 2-chloro-9-(oxolan-3-yl)-n-propylpurin-6-amine Chemical compound C1=NC=2C(NCCC)=NC(Cl)=NC=2N1C1CCOC1 JDSCHBFHVKTPOP-UHFFFAOYSA-N 0.000 description 2
- OPHQOIGEOHXOGX-UHFFFAOYSA-N 3,4,5-trimethoxybenzaldehyde Chemical compound COC1=CC(C=O)=CC(OC)=C1OC OPHQOIGEOHXOGX-UHFFFAOYSA-N 0.000 description 2
- 125000005809 3,4,5-trimethoxyphenyl group Chemical group [H]C1=C(OC([H])([H])[H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 description 2
- GSCPDZHWVNUUFI-UHFFFAOYSA-N 3-aminobenzamide Chemical compound NC(=O)C1=CC=CC(N)=C1 GSCPDZHWVNUUFI-UHFFFAOYSA-N 0.000 description 2
- MUBJNMWVQGHHLG-UHFFFAOYSA-N 3-bromobenzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC(Br)=C1 MUBJNMWVQGHHLG-UHFFFAOYSA-N 0.000 description 2
- 125000006305 3-iodophenyl group Chemical group [H]C1=C([H])C(I)=C([H])C(*)=C1[H] 0.000 description 2
- OXZYBOLWRXENKT-UHFFFAOYSA-N 4-(trifluoromethyl)benzoyl chloride Chemical compound FC(F)(F)C1=CC=C(C(Cl)=O)C=C1 OXZYBOLWRXENKT-UHFFFAOYSA-N 0.000 description 2
- QIKYZXDTTPVVAC-UHFFFAOYSA-N 4-Aminobenzamide Chemical compound NC(=O)C1=CC=C(N)C=C1 QIKYZXDTTPVVAC-UHFFFAOYSA-N 0.000 description 2
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 2
- RKIDDEGICSMIJA-UHFFFAOYSA-N 4-chlorobenzoyl chloride Chemical compound ClC(=O)C1=CC=C(Cl)C=C1 RKIDDEGICSMIJA-UHFFFAOYSA-N 0.000 description 2
- 125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 description 2
- KYDZEZNYRFJCSA-UHFFFAOYSA-N 4-tert-butylbenzenesulfonamide Chemical compound CC(C)(C)C1=CC=C(S(N)(=O)=O)C=C1 KYDZEZNYRFJCSA-UHFFFAOYSA-N 0.000 description 2
- PXRKCOCTEMYUEG-UHFFFAOYSA-N 5-aminoisoindole-1,3-dione Chemical compound NC1=CC=C2C(=O)NC(=O)C2=C1 PXRKCOCTEMYUEG-UHFFFAOYSA-N 0.000 description 2
- 108091007914 CDKs Proteins 0.000 description 2
- FGHQPKHGTJIJDT-WGSAOQKQSA-N COc1cc(CNCCNc2nc(N[C@H]3CC[C@H](N)CC3)nc3n(cnc23)C2CCCC2)cc2OCOc12 Chemical compound COc1cc(CNCCNc2nc(N[C@H]3CC[C@H](N)CC3)nc3n(cnc23)C2CCCC2)cc2OCOc12 FGHQPKHGTJIJDT-WGSAOQKQSA-N 0.000 description 2
- MHUCSTFQPDZMFU-RKQOQJRBSA-N Cl.Cl.C(C)OC(=O)C1=CC(=CC(=C1)NC1=C2N=CN(C2=NC(=N1)N[C@@H]1CC[C@H](CC1)N)C1CCCC1)C(=O)OCC Chemical compound Cl.Cl.C(C)OC(=O)C1=CC(=CC(=C1)NC1=C2N=CN(C2=NC(=N1)N[C@@H]1CC[C@H](CC1)N)C1CCCC1)C(=O)OCC MHUCSTFQPDZMFU-RKQOQJRBSA-N 0.000 description 2
- WIVQGHIWCTZDGQ-GVVKCMBXSA-N Cl.Cl.CCC(CC)n1cnc2c(Nc3ccc(OC(F)(F)F)cc3)nc(N[C@H]3CC[C@H](N)CC3)nc12 Chemical compound Cl.Cl.CCC(CC)n1cnc2c(Nc3ccc(OC(F)(F)F)cc3)nc(N[C@H]3CC[C@H](N)CC3)nc12 WIVQGHIWCTZDGQ-GVVKCMBXSA-N 0.000 description 2
- QZQSVPPMTLVZIJ-HEOZJBRKSA-N Cl.Cl.CCC(CC)n1cnc2c(Nc3ccccc3)nc(N[C@H]3CC[C@H](N)CC3)nc12 Chemical compound Cl.Cl.CCC(CC)n1cnc2c(Nc3ccccc3)nc(N[C@H]3CC[C@H](N)CC3)nc12 QZQSVPPMTLVZIJ-HEOZJBRKSA-N 0.000 description 2
- YWNCUICVAWMHLW-SYPRRBKESA-N Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccc(cc2)-c2ccccc2)c2ncn(C3CCCC3)c2n1 Chemical compound Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccc(cc2)-c2ccccc2)c2ncn(C3CCCC3)c2n1 YWNCUICVAWMHLW-SYPRRBKESA-N 0.000 description 2
- LKMOGYXCKJCDQJ-GJFNAKTISA-N Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccc(cc2)C#N)c2ncn(C3CCCC3)c2n1 Chemical compound Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccc(cc2)C#N)c2ncn(C3CCCC3)c2n1 LKMOGYXCKJCDQJ-GJFNAKTISA-N 0.000 description 2
- RRGVHNJIDBLSFG-GVVKCMBXSA-N Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccc(cc2)[N+]([O-])=O)c2ncn(C3CCCC3)c2n1 Chemical compound Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccc(cc2)[N+]([O-])=O)c2ncn(C3CCCC3)c2n1 RRGVHNJIDBLSFG-GVVKCMBXSA-N 0.000 description 2
- UMSKDTSCYHVLIL-XVFXJROOSA-N Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccccc2)c2ncn(C3CCOC3)c2n1 Chemical compound Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccccc2)c2ncn(C3CCOC3)c2n1 UMSKDTSCYHVLIL-XVFXJROOSA-N 0.000 description 2
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- PYLAXYSDCYDGJT-SWJWNNQRSA-N NC1CCC(CC1)Nc1ccc(cc1)S(=O)(=O)NCCNc1nc(N[C@H]2CC[C@H](N)CC2)nc2n(cnc12)C1CCCC1 Chemical compound NC1CCC(CC1)Nc1ccc(cc1)S(=O)(=O)NCCNc1nc(N[C@H]2CC[C@H](N)CC2)nc2n(cnc12)C1CCCC1 PYLAXYSDCYDGJT-SWJWNNQRSA-N 0.000 description 2
- UGYISBUPOFTOMT-QAQDUYKDSA-N N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNC(=O)c2ccc(Cl)c(Cl)c2)c2ncn(C3CCCC3)c2n1 Chemical compound N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNC(=O)c2ccc(Cl)c(Cl)c2)c2ncn(C3CCCC3)c2n1 UGYISBUPOFTOMT-QAQDUYKDSA-N 0.000 description 2
- MFYBYLFYGKWVGU-WKILWMFISA-N N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNC(=O)c2ccc(cc2Cl)[N+]([O-])=O)c2ncn(C3CCCC3)c2n1 Chemical compound N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNC(=O)c2ccc(cc2Cl)[N+]([O-])=O)c2ncn(C3CCCC3)c2n1 MFYBYLFYGKWVGU-WKILWMFISA-N 0.000 description 2
- AHDXMCJELDJBHL-IYARVYRRSA-N N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNC(=O)c2cccc(OC(F)(F)F)c2)c2ncn(C3CCCC3)c2n1 Chemical compound N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNC(=O)c2cccc(OC(F)(F)F)c2)c2ncn(C3CCCC3)c2n1 AHDXMCJELDJBHL-IYARVYRRSA-N 0.000 description 2
- DQPSNNMBZNOPAS-IYARVYRRSA-N N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNCc2ccc(Cl)c(Cl)c2)c2ncn(C3CCCC3)c2n1 Chemical compound N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNCc2ccc(Cl)c(Cl)c2)c2ncn(C3CCCC3)c2n1 DQPSNNMBZNOPAS-IYARVYRRSA-N 0.000 description 2
- XTAOZQLUVLLUIH-MXVIHJGJSA-N N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNCc2ccccc2)c2ncn(C3CCCC3)c2n1 Chemical compound N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNCc2ccccc2)c2ncn(C3CCCC3)c2n1 XTAOZQLUVLLUIH-MXVIHJGJSA-N 0.000 description 2
- ZGRLKEZUDIIUKZ-IYARVYRRSA-N N[C@H]1CC[C@@H](CC1)Nc1nc(NCc2ccc(cc2)C(O)=O)c2ncn(C3CCCC3)c2n1 Chemical compound N[C@H]1CC[C@@H](CC1)Nc1nc(NCc2ccc(cc2)C(O)=O)c2ncn(C3CCCC3)c2n1 ZGRLKEZUDIIUKZ-IYARVYRRSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 208000030852 Parasitic disease Diseases 0.000 description 2
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 230000009102 absorption Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000005903 acid hydrolysis reaction Methods 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 230000001028 anti-proliverative effect Effects 0.000 description 2
- 239000003080 antimitotic agent Substances 0.000 description 2
- 150000001540 azides Chemical class 0.000 description 2
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 2
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 2
- DMVOXQPQNTYEKQ-UHFFFAOYSA-N biphenyl-4-amine Chemical group C1=CC(N)=CC=C1C1=CC=CC=C1 DMVOXQPQNTYEKQ-UHFFFAOYSA-N 0.000 description 2
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Substances OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- OCDXZFSOHJRGIL-UHFFFAOYSA-N cyclohexyloxycyclohexane Chemical class C1CCCCC1OC1CCCCC1 OCDXZFSOHJRGIL-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- CFNDVXUTYPXOPG-UHFFFAOYSA-N ethyl 2-(4-aminophenyl)acetate Chemical compound CCOC(=O)CC1=CC=C(N)C=C1 CFNDVXUTYPXOPG-UHFFFAOYSA-N 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- QHWAQXOSHHKCFK-UHFFFAOYSA-N hexylcyclohexane Chemical class CCCCCCC1CCCCC1 QHWAQXOSHHKCFK-UHFFFAOYSA-N 0.000 description 2
- AMWRITDGCCNYAT-UHFFFAOYSA-L hydroxy(oxo)manganese;manganese Chemical compound [Mn].O[Mn]=O.O[Mn]=O AMWRITDGCCNYAT-UHFFFAOYSA-L 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 2
- VZDNXXPBYLGWOS-UHFFFAOYSA-N methyl 3-aminobenzoate Chemical compound COC(=O)C1=CC=CC(N)=C1 VZDNXXPBYLGWOS-UHFFFAOYSA-N 0.000 description 2
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 2
- 150000002825 nitriles Chemical group 0.000 description 2
- GTVPOLSIJWJJNY-UHFFFAOYSA-N olomoucine Chemical compound N1=C(NCCO)N=C2N(C)C=NC2=C1NCC1=CC=CC=C1 GTVPOLSIJWJJNY-UHFFFAOYSA-N 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 150000002923 oximes Chemical group 0.000 description 2
- AQIXEPGDORPWBJ-UHFFFAOYSA-N pentan-3-ol Chemical compound CCC(O)CC AQIXEPGDORPWBJ-UHFFFAOYSA-N 0.000 description 2
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 2
- 125000005544 phthalimido group Chemical group 0.000 description 2
- 229940072033 potash Drugs 0.000 description 2
- 235000015320 potassium carbonate Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- VVWRJUBEIPHGQF-UHFFFAOYSA-N propan-2-yl n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)N=NC(=O)OC(C)C VVWRJUBEIPHGQF-UHFFFAOYSA-N 0.000 description 2
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
- 229940124530 sulfonamide Drugs 0.000 description 2
- 150000003457 sulfones Chemical group 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- HERSKCAGZCXYMC-UHFFFAOYSA-N thiophen-3-ol Chemical compound OC=1C=CSC=1 HERSKCAGZCXYMC-UHFFFAOYSA-N 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- GRGCWBWNLSTIEN-UHFFFAOYSA-N trifluoromethanesulfonyl chloride Chemical compound FC(F)(F)S(Cl)(=O)=O GRGCWBWNLSTIEN-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- YKPQUSLRUFLVDA-UHFFFAOYSA-N $l^{2}-azanylmethane Chemical compound [NH]C YKPQUSLRUFLVDA-UHFFFAOYSA-N 0.000 description 1
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
- RMFWVOLULURGJI-UHFFFAOYSA-N 2,6-dichloro-7h-purine Chemical compound ClC1=NC(Cl)=C2NC=NC2=N1 RMFWVOLULURGJI-UHFFFAOYSA-N 0.000 description 1
- NHWXVMFKJPUCSX-UHFFFAOYSA-N 2,6-dichloro-9-(oxolan-3-yl)purine Chemical compound C12=NC(Cl)=NC(Cl)=C2N=CN1C1CCOC1 NHWXVMFKJPUCSX-UHFFFAOYSA-N 0.000 description 1
- CMYUXPKTNLTVJF-UHFFFAOYSA-N 2,6-dichloro-9-(thiolan-3-yl)purine Chemical compound C12=NC(Cl)=NC(Cl)=C2N=CN1C1CCSC1 CMYUXPKTNLTVJF-UHFFFAOYSA-N 0.000 description 1
- TVGDBGPLYZULGD-UHFFFAOYSA-N 2,6-dichloro-9-cyclopentylpurine Chemical compound C12=NC(Cl)=NC(Cl)=C2N=CN1C1CCCC1 TVGDBGPLYZULGD-UHFFFAOYSA-N 0.000 description 1
- GTQJBQLXSGFREX-UHFFFAOYSA-N 2,6-dichloro-9-pentan-3-ylpurine Chemical compound N1=C(Cl)N=C2N(C(CC)CC)C=NC2=C1Cl GTQJBQLXSGFREX-UHFFFAOYSA-N 0.000 description 1
- YCWRFIYBUQBHJI-UHFFFAOYSA-N 2-(4-aminophenyl)acetonitrile Chemical compound NC1=CC=C(CC#N)C=C1 YCWRFIYBUQBHJI-UHFFFAOYSA-N 0.000 description 1
- JLRPFNVTZSQGQW-UHFFFAOYSA-N 2-[4-[(2-chloro-9-cyclopentylpurin-6-yl)amino]phenyl]acetonitrile Chemical compound C=12N=CN(C3CCCC3)C2=NC(Cl)=NC=1NC1=CC=C(CC#N)C=C1 JLRPFNVTZSQGQW-UHFFFAOYSA-N 0.000 description 1
- UPPDHRZSRWBXQJ-UHFFFAOYSA-N 2-amino-5-[[6-(benzylamino)-9-cyclopentylpurin-2-yl]amino]cyclohexan-1-ol;dihydrochloride Chemical compound Cl.Cl.C1C(O)C(N)CCC1NC1=NC(NCC=2C=CC=CC=2)=C(N=CN2C3CCCC3)C2=N1 UPPDHRZSRWBXQJ-UHFFFAOYSA-N 0.000 description 1
- PGRFZZCPCJLPFY-UHFFFAOYSA-N 2-aminoethanol;pyridine Chemical compound NCCO.C1=CC=NC=C1 PGRFZZCPCJLPFY-UHFFFAOYSA-N 0.000 description 1
- AYUUKEMEFZPHQQ-UHFFFAOYSA-N 2-chloro-3-nitrobenzoyl chloride Chemical compound [O-][N+](=O)C1=CC=CC(C(Cl)=O)=C1Cl AYUUKEMEFZPHQQ-UHFFFAOYSA-N 0.000 description 1
- LBXVRYDAWJLTPP-UHFFFAOYSA-N 2-chloro-9-(oxolan-3-yl)-n-[4-(trifluoromethoxy)phenyl]purin-6-amine Chemical compound C1=CC(OC(F)(F)F)=CC=C1NC1=NC(Cl)=NC2=C1N=CN2C1COCC1 LBXVRYDAWJLTPP-UHFFFAOYSA-N 0.000 description 1
- DHLKWSBKYWTLTJ-UHFFFAOYSA-N 2-chloro-9-(thiolan-3-yl)-n-[4-(trifluoromethoxy)phenyl]purin-6-amine Chemical compound C1=CC(OC(F)(F)F)=CC=C1NC1=NC(Cl)=NC2=C1N=CN2C1CSCC1 DHLKWSBKYWTLTJ-UHFFFAOYSA-N 0.000 description 1
- VVCCZXKMOXYTNM-UHFFFAOYSA-N 2-chloro-9-cyclopentyl-n-(4-methoxyphenyl)purin-6-amine Chemical compound C1=CC(OC)=CC=C1NC1=NC(Cl)=NC2=C1N=CN2C1CCCC1 VVCCZXKMOXYTNM-UHFFFAOYSA-N 0.000 description 1
- VMVVZWVDCTWZKO-UHFFFAOYSA-N 2-chloro-9-cyclopentyl-n-(4-morpholin-4-ylphenyl)purin-6-amine Chemical compound C=12N=CN(C3CCCC3)C2=NC(Cl)=NC=1NC(C=C1)=CC=C1N1CCOCC1 VMVVZWVDCTWZKO-UHFFFAOYSA-N 0.000 description 1
- PMBPCLILTMBHAS-UHFFFAOYSA-N 2-chloro-9-cyclopentyl-n-(4-nitrophenyl)purin-6-amine Chemical compound C1=CC([N+](=O)[O-])=CC=C1NC1=NC(Cl)=NC2=C1N=CN2C1CCCC1 PMBPCLILTMBHAS-UHFFFAOYSA-N 0.000 description 1
- OUJGOPWCEDFBIV-UHFFFAOYSA-N 2-chloro-9-cyclopentyl-n-(4-phenylphenyl)purin-6-amine Chemical compound C=12N=CN(C3CCCC3)C2=NC(Cl)=NC=1NC(C=C1)=CC=C1C1=CC=CC=C1 OUJGOPWCEDFBIV-UHFFFAOYSA-N 0.000 description 1
- MWWYVVFQEVGYEZ-UHFFFAOYSA-N 2-chloro-9-cyclopentyl-n-[4-(trifluoromethyl)phenyl]purin-6-amine Chemical compound C1=CC(C(F)(F)F)=CC=C1NC1=NC(Cl)=NC2=C1N=CN2C1CCCC1 MWWYVVFQEVGYEZ-UHFFFAOYSA-N 0.000 description 1
- SOPSCIZOUSIZBH-UHFFFAOYSA-N 2-chloro-9-cyclopentyl-n-phenylpurin-6-amine Chemical compound C=12N=CN(C3CCCC3)C2=NC(Cl)=NC=1NC1=CC=CC=C1 SOPSCIZOUSIZBH-UHFFFAOYSA-N 0.000 description 1
- JQWHUCYPTGBVGV-UHFFFAOYSA-N 2-chloro-9-pentan-3-yl-n-[4-(trifluoromethoxy)phenyl]purin-6-amine Chemical compound N1=C(Cl)N=C2N(C(CC)CC)C=NC2=C1NC1=CC=C(OC(F)(F)F)C=C1 JQWHUCYPTGBVGV-UHFFFAOYSA-N 0.000 description 1
- ZKCUJEIFLJEGLQ-UHFFFAOYSA-N 2-chloro-9-pentan-3-yl-n-phenylpurin-6-amine Chemical compound N1=C(Cl)N=C2N(C(CC)CC)C=NC2=C1NC1=CC=CC=C1 ZKCUJEIFLJEGLQ-UHFFFAOYSA-N 0.000 description 1
- LYFDEZVSRMZHQE-UHFFFAOYSA-N 2-chloro-9-pentan-3-yl-n-propylpurin-6-amine Chemical compound CCCNC1=NC(Cl)=NC2=C1N=CN2C(CC)CC LYFDEZVSRMZHQE-UHFFFAOYSA-N 0.000 description 1
- DROWWEMDOGXVRX-UHFFFAOYSA-N 2-chloro-N-[(3-iodophenyl)methyl]-9-pentan-3-ylpurin-6-amine Chemical compound N1=C(Cl)N=C2N(C(CC)CC)C=NC2=C1NCC1=CC=CC(I)=C1 DROWWEMDOGXVRX-UHFFFAOYSA-N 0.000 description 1
- FSAXRNXWNOSEDP-UHFFFAOYSA-N 2-chloro-n-[(3-iodophenyl)methyl]-9-(oxolan-3-yl)purin-6-amine Chemical compound C=12N=CN(C3COCC3)C2=NC(Cl)=NC=1NCC1=CC=CC(I)=C1 FSAXRNXWNOSEDP-UHFFFAOYSA-N 0.000 description 1
- ZRGFSQMAXNGJFW-UHFFFAOYSA-N 2-chloro-n-[(3-iodophenyl)methyl]-9-(thiolan-3-yl)purin-6-amine Chemical compound C=12N=CN(C3CSCC3)C2=NC(Cl)=NC=1NCC1=CC=CC(I)=C1 ZRGFSQMAXNGJFW-UHFFFAOYSA-N 0.000 description 1
- JVCNVONHIMMTJU-UHFFFAOYSA-N 2-chloro-n-[2-[(2-chloro-9-cyclopentylpurin-6-yl)amino]ethyl]-4-nitrobenzamide Chemical compound ClC1=CC([N+](=O)[O-])=CC=C1C(=O)NCCNC1=NC(Cl)=NC2=C1N=CN2C1CCCC1 JVCNVONHIMMTJU-UHFFFAOYSA-N 0.000 description 1
- OAPYKKWUOHTSFD-UHFFFAOYSA-N 2-chloro-n-phenyl-9-(thiolan-3-yl)purin-6-amine Chemical compound C=12N=CN(C3CSCC3)C2=NC(Cl)=NC=1NC1=CC=CC=C1 OAPYKKWUOHTSFD-UHFFFAOYSA-N 0.000 description 1
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 1
- CTZQJPLXJFNKLY-UHFFFAOYSA-N 2-n-(4-aminocyclohexyl)-6-n-benzyl-9-(oxolan-3-yl)purine-2,6-diamine;dihydrochloride Chemical compound Cl.Cl.C1CC(N)CCC1NC1=NC(NCC=2C=CC=CC=2)=C(N=CN2C3COCC3)C2=N1 CTZQJPLXJFNKLY-UHFFFAOYSA-N 0.000 description 1
- NIBKWZHOGUHVIQ-UHFFFAOYSA-N 2-phenylacetonitrile dihydrochloride Chemical compound Cl.Cl.C(C1=CC=CC=C1)C#N NIBKWZHOGUHVIQ-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- RPPHLXGBYGEZAF-UHFFFAOYSA-N 3,4-dichloro-n-[2-[(2-chloro-9-cyclopentylpurin-6-yl)amino]ethyl]benzamide Chemical compound C=12N=CN(C3CCCC3)C2=NC(Cl)=NC=1NCCNC(=O)C1=CC=C(Cl)C(Cl)=C1 RPPHLXGBYGEZAF-UHFFFAOYSA-N 0.000 description 1
- ZWUSBSHBFFPRNE-UHFFFAOYSA-N 3,4-dichlorobenzaldehyde Chemical compound ClC1=CC=C(C=O)C=C1Cl ZWUSBSHBFFPRNE-UHFFFAOYSA-N 0.000 description 1
- VTXNOVCTHUBABW-UHFFFAOYSA-N 3,4-dichlorobenzoyl chloride Chemical compound ClC(=O)C1=CC=C(Cl)C(Cl)=C1 VTXNOVCTHUBABW-UHFFFAOYSA-N 0.000 description 1
- VIOBGCWEHLRBEP-UHFFFAOYSA-N 3,4-dimethoxybenzoyl chloride Chemical compound COC1=CC=C(C(Cl)=O)C=C1OC VIOBGCWEHLRBEP-UHFFFAOYSA-N 0.000 description 1
- LQNQATDDAOYQRX-UHFFFAOYSA-N 3,5-dichloro-n-[2-[(2-chloro-9-cyclopentylpurin-6-yl)amino]ethyl]benzamide Chemical compound ClC1=CC(Cl)=CC(C(=O)NCCNC=2C=3N=CN(C=3N=C(Cl)N=2)C2CCCC2)=C1 LQNQATDDAOYQRX-UHFFFAOYSA-N 0.000 description 1
- CASRSOJWLARCRX-UHFFFAOYSA-N 3,5-dichlorobenzaldehyde Chemical compound ClC1=CC(Cl)=CC(C=O)=C1 CASRSOJWLARCRX-UHFFFAOYSA-N 0.000 description 1
- GGHLXLVPNZMBQR-UHFFFAOYSA-N 3,5-dichlorobenzoyl chloride Chemical compound ClC(=O)C1=CC(Cl)=CC(Cl)=C1 GGHLXLVPNZMBQR-UHFFFAOYSA-N 0.000 description 1
- NZZZOYVRPOWZJQ-UHFFFAOYSA-N 3-(methylamino)benzamide Chemical compound CNC1=CC=CC(C(N)=O)=C1 NZZZOYVRPOWZJQ-UHFFFAOYSA-N 0.000 description 1
- OKPFIWIMBJNFSE-UHFFFAOYSA-N 3-(trifluoromethoxy)benzoic acid Chemical compound OC(=O)C1=CC=CC(OC(F)(F)F)=C1 OKPFIWIMBJNFSE-UHFFFAOYSA-N 0.000 description 1
- ZUTVRDMZQSHCID-UHFFFAOYSA-N 3-(trifluoromethyl)benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC(C(F)(F)F)=C1 ZUTVRDMZQSHCID-UHFFFAOYSA-N 0.000 description 1
- IFMANFAYWLTAGD-UHFFFAOYSA-N 3-[(2-chloro-9-cyclopentylpurin-6-yl)amino]benzamide Chemical compound NC(=O)C1=CC=CC(NC=2C=3N=CN(C=3N=C(Cl)N=2)C2CCCC2)=C1 IFMANFAYWLTAGD-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- NSTFOYCMWFSKFK-UHFFFAOYSA-N 3-bromo-n'-(2-chloro-9-cyclopentylpurin-6-yl)benzenesulfonohydrazide Chemical compound C=12N=CN(C3CCCC3)C2=NC(Cl)=NC=1NNS(=O)(=O)C1=CC=CC(Br)=C1 NSTFOYCMWFSKFK-UHFFFAOYSA-N 0.000 description 1
- TXYWFDDLFUNVOL-UHFFFAOYSA-N 3-chloro-n-[2-[(2-chloro-9-cyclopentylpurin-6-yl)amino]ethyl]benzamide Chemical compound ClC1=CC=CC(C(=O)NCCNC=2C=3N=CN(C=3N=C(Cl)N=2)C2CCCC2)=C1 TXYWFDDLFUNVOL-UHFFFAOYSA-N 0.000 description 1
- SRWILAKSARHZPR-UHFFFAOYSA-N 3-chlorobenzaldehyde Chemical compound ClC1=CC=CC(C=O)=C1 SRWILAKSARHZPR-UHFFFAOYSA-N 0.000 description 1
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 1
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 description 1
- FQXQBFUUVCDIRK-UHFFFAOYSA-N 3-trifluoromethylbenzoic acid Chemical compound OC(=O)C1=CC=CC(C(F)(F)F)=C1 FQXQBFUUVCDIRK-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- AROGTOONLWKAQP-UHFFFAOYSA-N 4-(fluoromethoxy)benzaldehyde Chemical compound FCOC1=CC=C(C=O)C=C1 AROGTOONLWKAQP-UHFFFAOYSA-N 0.000 description 1
- XQNVDQZWOBPLQZ-UHFFFAOYSA-N 4-(trifluoromethoxy)benzaldehyde Chemical compound FC(F)(F)OC1=CC=C(C=O)C=C1 XQNVDQZWOBPLQZ-UHFFFAOYSA-N 0.000 description 1
- BEOBZEOPTQQELP-UHFFFAOYSA-N 4-(trifluoromethyl)benzaldehyde Chemical compound FC(F)(F)C1=CC=C(C=O)C=C1 BEOBZEOPTQQELP-UHFFFAOYSA-N 0.000 description 1
- RLTPXEAFDJVHSN-UHFFFAOYSA-N 4-(trifluoromethyl)benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=C(C(F)(F)F)C=C1 RLTPXEAFDJVHSN-UHFFFAOYSA-N 0.000 description 1
- QXIDPLJFIVNPMA-UHFFFAOYSA-N 4-[(2-chloro-9-cyclopentylpurin-6-yl)amino]-n-(1,3-thiazol-2-yl)benzenesulfonamide Chemical compound C=12N=CN(C3CCCC3)C2=NC(Cl)=NC=1NC(C=C1)=CC=C1S(=O)(=O)NC1=NC=CS1 QXIDPLJFIVNPMA-UHFFFAOYSA-N 0.000 description 1
- MUSGPBLMDJYJFX-UHFFFAOYSA-N 4-[(2-chloro-9-cyclopentylpurin-6-yl)amino]benzamide Chemical compound C1=CC(C(=O)N)=CC=C1NC1=NC(Cl)=NC2=C1N=CN2C1CCCC1 MUSGPBLMDJYJFX-UHFFFAOYSA-N 0.000 description 1
- GZNGIFPBSHYMKA-UHFFFAOYSA-N 4-[(2-chloro-9-cyclopentylpurin-6-yl)amino]benzenesulfonamide Chemical compound C1=CC(S(=O)(=O)N)=CC=C1NC1=NC(Cl)=NC2=C1N=CN2C1CCCC1 GZNGIFPBSHYMKA-UHFFFAOYSA-N 0.000 description 1
- DAEZVLAETGNZDQ-UHFFFAOYSA-N 4-[(2-chloro-9-cyclopentylpurin-6-yl)amino]benzonitrile Chemical compound C=12N=CN(C3CCCC3)C2=NC(Cl)=NC=1NC1=CC=C(C#N)C=C1 DAEZVLAETGNZDQ-UHFFFAOYSA-N 0.000 description 1
- WKDRXAYWMPQBAY-UHFFFAOYSA-N 4-[[2-[(2-chloro-9-cyclopentylpurin-6-yl)amino]ethylamino]methyl]benzonitrile Chemical compound C=12N=CN(C3CCCC3)C2=NC(Cl)=NC=1NCCNCC1=CC=C(C#N)C=C1 WKDRXAYWMPQBAY-UHFFFAOYSA-N 0.000 description 1
- GCTYHCFILCSUKE-UHFFFAOYSA-N 4-[[6-(benzylamino)-9-cyclopentylpurin-2-yl]amino]cyclohexan-1-one;dihydrochloride Chemical compound Cl.Cl.C1CC(=O)CCC1NC1=NC(NCC=2C=CC=CC=2)=C(N=CN2C3CCCC3)C2=N1 GCTYHCFILCSUKE-UHFFFAOYSA-N 0.000 description 1
- YBAZINRZQSAIAY-UHFFFAOYSA-N 4-aminobenzonitrile Chemical compound NC1=CC=C(C#N)C=C1 YBAZINRZQSAIAY-UHFFFAOYSA-N 0.000 description 1
- DRNGLYHKYPNTEA-UHFFFAOYSA-N 4-azaniumylcyclohexane-1-carboxylate Chemical compound NC1CCC(C(O)=O)CC1 DRNGLYHKYPNTEA-UHFFFAOYSA-N 0.000 description 1
- GUWINIJWCZETJB-UHFFFAOYSA-N 4-bromo-n'-(2-chloro-9-cyclopentylpurin-6-yl)benzenesulfonohydrazide Chemical compound C=12N=CN(C3CCCC3)C2=NC(Cl)=NC=1NNS(=O)(=O)C1=CC=C(Br)C=C1 GUWINIJWCZETJB-UHFFFAOYSA-N 0.000 description 1
- STYQHICBPYRHQK-UHFFFAOYSA-N 4-bromobenzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=C(Br)C=C1 STYQHICBPYRHQK-UHFFFAOYSA-N 0.000 description 1
- NIHMMULLFBKTOK-UHFFFAOYSA-N 4-chloro-3-(trifluoromethyl)benzaldehyde Chemical compound FC(F)(F)C1=CC(C=O)=CC=C1Cl NIHMMULLFBKTOK-UHFFFAOYSA-N 0.000 description 1
- ZIQBOLKDNPFOMV-UHFFFAOYSA-N 4-chloro-n-[2-[(2-chloro-9-cyclopentylpurin-6-yl)amino]ethyl]benzamide Chemical compound C1=CC(Cl)=CC=C1C(=O)NCCNC1=NC(Cl)=NC2=C1N=CN2C1CCCC1 ZIQBOLKDNPFOMV-UHFFFAOYSA-N 0.000 description 1
- KXFOVIFEYSLPKN-UHFFFAOYSA-N 4-chloro-n-[2-[(2-chloro-9-cyclopentylpurin-6-yl)amino]ethyl]benzenesulfonamide Chemical compound C1=CC(Cl)=CC=C1S(=O)(=O)NCCNC1=NC(Cl)=NC2=C1N=CN2C1CCCC1 KXFOVIFEYSLPKN-UHFFFAOYSA-N 0.000 description 1
- AVPYQKSLYISFPO-UHFFFAOYSA-N 4-chlorobenzaldehyde Chemical compound ClC1=CC=C(C=O)C=C1 AVPYQKSLYISFPO-UHFFFAOYSA-N 0.000 description 1
- ZLYBFBAHAQEEQQ-UHFFFAOYSA-N 4-chlorobenzenesulfonyl chloride Chemical compound ClC1=CC=C(S(Cl)(=O)=O)C=C1 ZLYBFBAHAQEEQQ-UHFFFAOYSA-N 0.000 description 1
- WZWIQYMTQZCSKI-UHFFFAOYSA-N 4-cyanobenzaldehyde Chemical compound O=CC1=CC=C(C#N)C=C1 WZWIQYMTQZCSKI-UHFFFAOYSA-N 0.000 description 1
- ILKGEOVHANZEFC-UHFFFAOYSA-N 4-ethoxybenzenesulfonamide Chemical compound CCOC1=CC=C(S(N)(=O)=O)C=C1 ILKGEOVHANZEFC-UHFFFAOYSA-N 0.000 description 1
- BFXHJFKKRGVUMU-UHFFFAOYSA-N 4-fluorobenzenesulfonyl chloride Chemical compound FC1=CC=C(S(Cl)(=O)=O)C=C1 BFXHJFKKRGVUMU-UHFFFAOYSA-N 0.000 description 1
- CZKLEJHVLCMVQR-UHFFFAOYSA-N 4-fluorobenzoyl chloride Chemical compound FC1=CC=C(C(Cl)=O)C=C1 CZKLEJHVLCMVQR-UHFFFAOYSA-N 0.000 description 1
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 1
- DTJVECUKADWGMO-UHFFFAOYSA-N 4-methoxybenzenesulfonyl chloride Chemical compound COC1=CC=C(S(Cl)(=O)=O)C=C1 DTJVECUKADWGMO-UHFFFAOYSA-N 0.000 description 1
- KWHCPERWLHBLOT-UHFFFAOYSA-N 4-methylsulfanylbenzoic acid Chemical compound CSC1=CC=C(C(O)=O)C=C1 KWHCPERWLHBLOT-UHFFFAOYSA-N 0.000 description 1
- PHNDZBFLOPIMSM-UHFFFAOYSA-N 4-morpholin-4-ylaniline Chemical compound C1=CC(N)=CC=C1N1CCOCC1 PHNDZBFLOPIMSM-UHFFFAOYSA-N 0.000 description 1
- TYMLOMAKGOJONV-UHFFFAOYSA-N 4-nitroaniline Chemical compound NC1=CC=C([N+]([O-])=O)C=C1 TYMLOMAKGOJONV-UHFFFAOYSA-N 0.000 description 1
- WVOWEROKBOQYLJ-UHFFFAOYSA-N 4-propan-2-ylbenzenesulfonamide Chemical compound CC(C)C1=CC=C(S(N)(=O)=O)C=C1 WVOWEROKBOQYLJ-UHFFFAOYSA-N 0.000 description 1
- YDUXMFLSHKJCHS-UHFFFAOYSA-N 4-tert-butyl-n'-(2-chloro-9-cyclopentylpurin-6-yl)benzenesulfonohydrazide Chemical compound C1=CC(C(C)(C)C)=CC=C1S(=O)(=O)NNC1=NC(Cl)=NC2=C1N=CN2C1CCCC1 YDUXMFLSHKJCHS-UHFFFAOYSA-N 0.000 description 1
- ODGIMMLDVSWADK-UHFFFAOYSA-N 4-trifluoromethylaniline Chemical compound NC1=CC=C(C(F)(F)F)C=C1 ODGIMMLDVSWADK-UHFFFAOYSA-N 0.000 description 1
- JDLCNPVMTRZGHJ-UHFFFAOYSA-N 5-amino-2-[[6-(benzylamino)-9-cyclopentylpurin-2-yl]amino]cyclohexan-1-ol;dihydrochloride Chemical compound Cl.Cl.OC1CC(N)CCC1NC1=NC(NCC=2C=CC=CC=2)=C(N=CN2C3CCCC3)C2=N1 JDLCNPVMTRZGHJ-UHFFFAOYSA-N 0.000 description 1
- QITVMZRFZGJDBY-UHFFFAOYSA-N 6-N-benzyl-9-cyclopentyl-2-N-(4-methoxyiminocyclohexyl)purine-2,6-diamine dihydrochloride Chemical compound CON=C1CCC(CC1)NC2=NC(=C3C(=N2)N(C=N3)C4CCCC4)NCC5=CC=CC=C5.Cl.Cl QITVMZRFZGJDBY-UHFFFAOYSA-N 0.000 description 1
- USQCUKQZXOWUDF-YWZLYKJASA-N 6-chloro-n-[(3s)-1-[(2s)-1-(4-methyl-5-oxo-1,4-diazepan-1-yl)-1-oxopropan-2-yl]-2-oxopyrrolidin-3-yl]naphthalene-2-sulfonamide Chemical compound O=C([C@@H](N1C([C@@H](NS(=O)(=O)C=2C=C3C=CC(Cl)=CC3=CC=2)CC1)=O)C)N1CCN(C)C(=O)CC1 USQCUKQZXOWUDF-YWZLYKJASA-N 0.000 description 1
- LOFRBHZYZCIOJO-UHFFFAOYSA-N 7-methoxy-1,3-benzodioxole-5-carbaldehyde Chemical compound COC1=CC(C=O)=CC2=C1OCO2 LOFRBHZYZCIOJO-UHFFFAOYSA-N 0.000 description 1
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
- DPIVFELOHSPJRF-UHFFFAOYSA-N 8-(4-aminocyclohexyl)-6-N-[(3-iodophenyl)methyl]-9-pentan-3-ylpurine-2,6-diamine Chemical compound NC1CCC(CC1)C=1N(C2=NC(=NC(=C2N=1)NCC1=CC(=CC=C1)I)N)C(CC)CC DPIVFELOHSPJRF-UHFFFAOYSA-N 0.000 description 1
- WXANDLAEEWIPHI-UHFFFAOYSA-N 8-(4-aminocyclohexyl)-6-N-[(3-iodophenyl)methyl]-9-pentan-3-ylpurine-2,6-diamine dihydrochloride Chemical compound Cl.Cl.N1=C(N)N=C2N(C(CC)CC)C(C3CCC(N)CC3)=NC2=C1NCC1=CC=CC(I)=C1 WXANDLAEEWIPHI-UHFFFAOYSA-N 0.000 description 1
- NRDPEAYCIFBSSJ-UHFFFAOYSA-N 9-butan-2-yl-2,6-dichloropurine Chemical compound N1=C(Cl)N=C2N(C(C)CC)C=NC2=C1Cl NRDPEAYCIFBSSJ-UHFFFAOYSA-N 0.000 description 1
- DXJLAFFRULQBFO-UHFFFAOYSA-N 9-butan-2-yl-2-chloro-n-[(3-iodophenyl)methyl]purin-6-amine Chemical compound N1=C(Cl)N=C2N(C(C)CC)C=NC2=C1NCC1=CC=CC(I)=C1 DXJLAFFRULQBFO-UHFFFAOYSA-N 0.000 description 1
- ALVUQJMXAXUWGB-UHFFFAOYSA-N 9-butan-2-yl-2-chloro-n-[4-(trifluoromethoxy)phenyl]purin-6-amine Chemical compound N1=C(Cl)N=C2N(C(C)CC)C=NC2=C1NC1=CC=C(OC(F)(F)F)C=C1 ALVUQJMXAXUWGB-UHFFFAOYSA-N 0.000 description 1
- SMEQPZPPGJZADL-UHFFFAOYSA-N 9-butan-2-yl-2-chloro-n-phenylpurin-6-amine Chemical compound N1=C(Cl)N=C2N(C(C)CC)C=NC2=C1NC1=CC=CC=C1 SMEQPZPPGJZADL-UHFFFAOYSA-N 0.000 description 1
- YSAVHHALZCIIOE-UHFFFAOYSA-N 9-butan-2-yl-2-chloro-n-propylpurin-6-amine Chemical compound CCCNC1=NC(Cl)=NC2=C1N=CN2C(C)CC YSAVHHALZCIIOE-UHFFFAOYSA-N 0.000 description 1
- MSSXOMSJDRHRMC-UHFFFAOYSA-N 9H-purine-2,6-diamine Chemical compound NC1=NC(N)=C2NC=NC2=N1 MSSXOMSJDRHRMC-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
- XRNLECHJVOZQTE-QSPIWVMWSA-N CCCNc1nc(N[C@H]2CC[C@H](N)CC2)nc2n(cnc12)C1CCOC1 Chemical compound CCCNc1nc(N[C@H]2CC[C@H](N)CC2)nc2n(cnc12)C1CCOC1 XRNLECHJVOZQTE-QSPIWVMWSA-N 0.000 description 1
- 101150012716 CDK1 gene Proteins 0.000 description 1
- XYPORYQGHRDGMG-MXVIHJGJSA-N COc1ccc(CNCCNc2nc(N[C@H]3CC[C@H](N)CC3)nc3n(cnc23)C2CCCC2)cc1 Chemical compound COc1ccc(CNCCNc2nc(N[C@H]3CC[C@H](N)CC3)nc3n(cnc23)C2CCCC2)cc1 XYPORYQGHRDGMG-MXVIHJGJSA-N 0.000 description 1
- MGYWWCKTAWMMDH-JCNLHEQBSA-N COc1ccc(Nc2nc(N[C@H]3CC[C@H](N)CC3)nc3n(cnc23)C2CCCC2)cc1 Chemical compound COc1ccc(Nc2nc(N[C@H]3CC[C@H](N)CC3)nc3n(cnc23)C2CCCC2)cc1 MGYWWCKTAWMMDH-JCNLHEQBSA-N 0.000 description 1
- ZIYLZLUPFHDADE-WGSAOQKQSA-N COc1ccc(cc1OC)C(=O)NCCNc1nc(N[C@H]2CC[C@H](N)CC2)nc2n(cnc12)C1CCCC1 Chemical compound COc1ccc(cc1OC)C(=O)NCCNc1nc(N[C@H]2CC[C@H](N)CC2)nc2n(cnc12)C1CCCC1 ZIYLZLUPFHDADE-WGSAOQKQSA-N 0.000 description 1
- PUPZSJZZYKCRIZ-WGSAOQKQSA-N CSc1ccc(cc1)C(=O)NCCNc1nc(N[C@H]2CC[C@H](N)CC2)nc2n(cnc12)C1CCCC1 Chemical compound CSc1ccc(cc1)C(=O)NCCNc1nc(N[C@H]2CC[C@H](N)CC2)nc2n(cnc12)C1CCCC1 PUPZSJZZYKCRIZ-WGSAOQKQSA-N 0.000 description 1
- 101100005789 Caenorhabditis elegans cdk-4 gene Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 101150053721 Cdk5 gene Proteins 0.000 description 1
- 101710178035 Chorismate synthase 2 Proteins 0.000 description 1
- VFIDXOGZJSJHDL-VAJGKAQFSA-N Cl.Cl.C1=CC(OCC)=CC=C1S(=O)(=O)NC1=NC(N[C@@H]2CC[C@@H](N)CC2)=NC2=C1N=CN2C1CCCC1 Chemical compound Cl.Cl.C1=CC(OCC)=CC=C1S(=O)(=O)NC1=NC(N[C@@H]2CC[C@@H](N)CC2)=NC2=C1N=CN2C1CCCC1 VFIDXOGZJSJHDL-VAJGKAQFSA-N 0.000 description 1
- JBAQOWJVYPUHNA-VAJGKAQFSA-N Cl.Cl.C1C[C@@H](N)CC[C@@H]1NC1=NC(NC(=O)C=2C=CC=CC=2)=C(N=CN2C3CCCC3)C2=N1 Chemical compound Cl.Cl.C1C[C@@H](N)CC[C@@H]1NC1=NC(NC(=O)C=2C=CC=CC=2)=C(N=CN2C3CCCC3)C2=N1 JBAQOWJVYPUHNA-VAJGKAQFSA-N 0.000 description 1
- RKNLYZUMBQHPRM-HLDGVKIBSA-N Cl.Cl.C1C[C@@H](N)CC[C@@H]1NC1=NC(NS(=O)(=O)C=2C=C(Br)C=CC=2)=C(N=CN2C3CCCC3)C2=N1 Chemical compound Cl.Cl.C1C[C@@H](N)CC[C@@H]1NC1=NC(NS(=O)(=O)C=2C=C(Br)C=CC=2)=C(N=CN2C3CCCC3)C2=N1 RKNLYZUMBQHPRM-HLDGVKIBSA-N 0.000 description 1
- WCBPSHAKOUUJIJ-HLDGVKIBSA-N Cl.Cl.C1C[C@@H](N)CC[C@@H]1NC1=NC(NS(=O)(=O)C=2C=CC(Br)=CC=2)=C(N=CN2C3CCCC3)C2=N1 Chemical compound Cl.Cl.C1C[C@@H](N)CC[C@@H]1NC1=NC(NS(=O)(=O)C=2C=CC(Br)=CC=2)=C(N=CN2C3CCCC3)C2=N1 WCBPSHAKOUUJIJ-HLDGVKIBSA-N 0.000 description 1
- AOBDJTZQMUQRJA-HLDGVKIBSA-N Cl.Cl.C1C[C@@H](N)CC[C@@H]1NC1=NC(NS(=O)(=O)C=2C=CC=CC=2)=C(N=CN2C3CCCC3)C2=N1 Chemical compound Cl.Cl.C1C[C@@H](N)CC[C@@H]1NC1=NC(NS(=O)(=O)C=2C=CC=CC=2)=C(N=CN2C3CCCC3)C2=N1 AOBDJTZQMUQRJA-HLDGVKIBSA-N 0.000 description 1
- VZGGKNMFTAABFU-UFLMWKHXSA-N Cl.Cl.C1C[C@@H](N)CC[C@@H]1OC1=NC(NCC=2C=CC=CC=2)=C(N=CN2C3CCCC3)C2=N1 Chemical compound Cl.Cl.C1C[C@@H](N)CC[C@@H]1OC1=NC(NCC=2C=CC=CC=2)=C(N=CN2C3CCCC3)C2=N1 VZGGKNMFTAABFU-UFLMWKHXSA-N 0.000 description 1
- DKVAQXJLUDXGLP-PYRPBJLNSA-N Cl.Cl.CCC(C)n1cnc2c(NCc3cccc(I)c3)nc(N[C@H]3CC[C@H](N)CC3)nc12 Chemical compound Cl.Cl.CCC(C)n1cnc2c(NCc3cccc(I)c3)nc(N[C@H]3CC[C@H](N)CC3)nc12 DKVAQXJLUDXGLP-PYRPBJLNSA-N 0.000 description 1
- NAMFEHSNVMXGKU-ARKAGGOSSA-N Cl.Cl.CCC(C)n1cnc2c(Nc3ccc(OC(F)(F)F)cc3)nc(N[C@H]3CC[C@H](N)CC3)nc12 Chemical compound Cl.Cl.CCC(C)n1cnc2c(Nc3ccc(OC(F)(F)F)cc3)nc(N[C@H]3CC[C@H](N)CC3)nc12 NAMFEHSNVMXGKU-ARKAGGOSSA-N 0.000 description 1
- OQIZZFMGBQPEJN-RSNMGLNFSA-N Cl.Cl.CCC(C)n1cnc2c(Nc3ccccc3)nc(N[C@H]3CC[C@H](N)CC3)nc12 Chemical compound Cl.Cl.CCC(C)n1cnc2c(Nc3ccccc3)nc(N[C@H]3CC[C@H](N)CC3)nc12 OQIZZFMGBQPEJN-RSNMGLNFSA-N 0.000 description 1
- ZKFJYQORWMHIRW-ADRWEOJYSA-N Cl.Cl.CCCNc1nc(N[C@H]2CC[C@H](N)CC2)nc2n(cnc12)C(C)CC Chemical compound Cl.Cl.CCCNc1nc(N[C@H]2CC[C@H](N)CC2)nc2n(cnc12)C(C)CC ZKFJYQORWMHIRW-ADRWEOJYSA-N 0.000 description 1
- KOHGFVFUDSJUDO-MXPSUWBQSA-N Cl.Cl.CCCNc1nc(N[C@H]2CC[C@H](N)CC2)nc2n(cnc12)C(CC)CC Chemical compound Cl.Cl.CCCNc1nc(N[C@H]2CC[C@H](N)CC2)nc2n(cnc12)C(CC)CC KOHGFVFUDSJUDO-MXPSUWBQSA-N 0.000 description 1
- NMDNZQDMCAUSCJ-BJFPXTTKSA-N Cl.Cl.CCCNc1nc(N[C@H]2CC[C@H](N)CC2)nc2n(cnc12)C1CCOC1 Chemical compound Cl.Cl.CCCNc1nc(N[C@H]2CC[C@H](N)CC2)nc2n(cnc12)C1CCOC1 NMDNZQDMCAUSCJ-BJFPXTTKSA-N 0.000 description 1
- QIYVTOZIZUNLHQ-BJFPXTTKSA-N Cl.Cl.CCCNc1nc(N[C@H]2CC[C@H](N)CC2)nc2n(cnc12)C1CCSC1 Chemical compound Cl.Cl.CCCNc1nc(N[C@H]2CC[C@H](N)CC2)nc2n(cnc12)C1CCSC1 QIYVTOZIZUNLHQ-BJFPXTTKSA-N 0.000 description 1
- MVUZCWTVSIZEOZ-HEWGHVJBSA-N Cl.Cl.COc1ccc(cc1)C(=O)NCCNc1nc(N[C@H]2CC[C@H](N)CC2)nc2n(cnc12)C1CCCC1 Chemical compound Cl.Cl.COc1ccc(cc1)C(=O)NCCNc1nc(N[C@H]2CC[C@H](N)CC2)nc2n(cnc12)C1CCCC1 MVUZCWTVSIZEOZ-HEWGHVJBSA-N 0.000 description 1
- KDNNOMQLJNGBAX-UHFFFAOYSA-N Cl.Cl.NC1CCC(CC1)C1=NC(=C2N=CN(C2=N1)C1CSCC1)NCCC Chemical compound Cl.Cl.NC1CCC(CC1)C1=NC(=C2N=CN(C2=N1)C1CSCC1)NCCC KDNNOMQLJNGBAX-UHFFFAOYSA-N 0.000 description 1
- NJTWUMADPAQTHA-UHFFFAOYSA-N Cl.Cl.NS(=O)(=O)C(F)(F)F Chemical compound Cl.Cl.NS(=O)(=O)C(F)(F)F NJTWUMADPAQTHA-UHFFFAOYSA-N 0.000 description 1
- MCWJXEWMMQZVJE-BCHJJPDRSA-N Cl.Cl.N[C@@H]1CC[C@H](CC1)NC1=NC(=C2N=CN(C2=N1)C1CCCC1)NS(=O)(=O)C=1C=NC=CC1 Chemical compound Cl.Cl.N[C@@H]1CC[C@H](CC1)NC1=NC(=C2N=CN(C2=N1)C1CCCC1)NS(=O)(=O)C=1C=NC=CC1 MCWJXEWMMQZVJE-BCHJJPDRSA-N 0.000 description 1
- CTZQJPLXJFNKLY-WTQXULBFSA-N Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(NCc2ccccc2)c2ncn(C3CCOC3)c2n1 Chemical compound Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(NCc2ccccc2)c2ncn(C3CCOC3)c2n1 CTZQJPLXJFNKLY-WTQXULBFSA-N 0.000 description 1
- MOLMLTXMDRSTNY-WTQXULBFSA-N Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(NCc2ccccc2)c2ncn(C3CCSC3)c2n1 Chemical compound Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(NCc2ccccc2)c2ncn(C3CCSC3)c2n1 MOLMLTXMDRSTNY-WTQXULBFSA-N 0.000 description 1
- QCXRKDDGPNLFIF-HEOZJBRKSA-N Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccc(cc2)C(F)(F)F)c2ncn(C3CCCC3)c2n1 Chemical compound Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccc(cc2)C(F)(F)F)c2ncn(C3CCCC3)c2n1 QCXRKDDGPNLFIF-HEOZJBRKSA-N 0.000 description 1
- CELYKGYCFHUDTP-GJFNAKTISA-N Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccc(cc2)S(=O)(=O)Nc2nccs2)c2ncn(C3CCCC3)c2n1 Chemical compound Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccc(cc2)S(=O)(=O)Nc2nccs2)c2ncn(C3CCCC3)c2n1 CELYKGYCFHUDTP-GJFNAKTISA-N 0.000 description 1
- WTRCEDDDFKCNAP-HLDGVKIBSA-N Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2cccc(c2)C(N)=O)c2ncn(C3CCCC3)c2n1 Chemical compound Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2cccc(c2)C(N)=O)c2ncn(C3CCCC3)c2n1 WTRCEDDDFKCNAP-HLDGVKIBSA-N 0.000 description 1
- GZNLVFMBXKFGFO-XVFXJROOSA-N Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccccc2)c2ncn(C3CCSC3)c2n1 Chemical compound Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccccc2)c2ncn(C3CCSC3)c2n1 GZNLVFMBXKFGFO-XVFXJROOSA-N 0.000 description 1
- FJEHRQUMJUVPHG-HPGRIBHPSA-N Cl.O[C@H]1CC[C@@H](CC1)Nc1nc(NCc2ccccc2)c2ncn(C3CCCC3)c2n1 Chemical compound Cl.O[C@H]1CC[C@@H](CC1)Nc1nc(NCc2ccccc2)c2ncn(C3CCCC3)c2n1 FJEHRQUMJUVPHG-HPGRIBHPSA-N 0.000 description 1
- UYFCDGLZPZOCLG-AELULUIVSA-N Cl.O[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccccc2)c2ncn(C3CCCC3)c2n1 Chemical compound Cl.O[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccccc2)c2ncn(C3CCCC3)c2n1 UYFCDGLZPZOCLG-AELULUIVSA-N 0.000 description 1
- 102100025840 Coiled-coil domain-containing protein 86 Human genes 0.000 description 1
- 108050006400 Cyclin Proteins 0.000 description 1
- 102000016736 Cyclin Human genes 0.000 description 1
- 102000003903 Cyclin-dependent kinases Human genes 0.000 description 1
- 108090000266 Cyclin-dependent kinases Proteins 0.000 description 1
- 101710152694 Cysteine synthase 2 Proteins 0.000 description 1
- 239000012625 DNA intercalator Substances 0.000 description 1
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical compound C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 101100059559 Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) nimX gene Proteins 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 101000932708 Homo sapiens Coiled-coil domain-containing protein 86 Proteins 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 239000003810 Jones reagent Substances 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GMPKIPWJBDOURN-UHFFFAOYSA-N Methoxyamine Chemical compound CON GMPKIPWJBDOURN-UHFFFAOYSA-N 0.000 description 1
- 102000007474 Multiprotein Complexes Human genes 0.000 description 1
- 108010085220 Multiprotein Complexes Proteins 0.000 description 1
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 1
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 description 1
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
- WTIMSEXUIWICBD-UHFFFAOYSA-N N=1C=2N(C(C)CC)C=NC=2C(NCCC)=NC=1NC1CCC(N)CC1 Chemical compound N=1C=2N(C(C)CC)C=NC=2C(NCCC)=NC=1NC1CCC(N)CC1 WTIMSEXUIWICBD-UHFFFAOYSA-N 0.000 description 1
- NZOXKXXKFOALOH-SYPQHRIQSA-N N[C@@H]1CC[C@H](CC1)NC1=NC(=C2N=CN(C2=N1)C1CSCC1)NC1=CC=C(C(=O)O)C=C1 Chemical compound N[C@@H]1CC[C@H](CC1)NC1=NC(=C2N=CN(C2=N1)C1CSCC1)NC1=CC=C(C(=O)O)C=C1 NZOXKXXKFOALOH-SYPQHRIQSA-N 0.000 description 1
- VSWGGLDAGWXLHF-WGSAOQKQSA-N N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNC(=O)c2cc(Cl)cc(Cl)c2)c2ncn(C3CCCC3)c2n1 Chemical compound N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNC(=O)c2cc(Cl)cc(Cl)c2)c2ncn(C3CCCC3)c2n1 VSWGGLDAGWXLHF-WGSAOQKQSA-N 0.000 description 1
- CMYRZZHXKMCPND-WGSAOQKQSA-N N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNC(=O)c2ccc(cc2)C(F)(F)F)c2ncn(C3CCCC3)c2n1 Chemical compound N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNC(=O)c2ccc(cc2)C(F)(F)F)c2ncn(C3CCCC3)c2n1 CMYRZZHXKMCPND-WGSAOQKQSA-N 0.000 description 1
- WXJWOXHKTUHYHK-WGSAOQKQSA-N N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNC(=O)c2cccc(c2)C(F)(F)F)c2ncn(C3CCCC3)c2n1 Chemical compound N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNC(=O)c2cccc(c2)C(F)(F)F)c2ncn(C3CCCC3)c2n1 WXJWOXHKTUHYHK-WGSAOQKQSA-N 0.000 description 1
- PJCXALXYKSPAJD-IYARVYRRSA-N N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNCc2ccc(Cl)c(c2)C(F)(F)F)c2ncn(C3CCCC3)c2n1 Chemical compound N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNCc2ccc(Cl)c(c2)C(F)(F)F)c2ncn(C3CCCC3)c2n1 PJCXALXYKSPAJD-IYARVYRRSA-N 0.000 description 1
- OOIOAGNTKVNFIT-MXVIHJGJSA-N N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNCc2ccc(Cl)cc2)c2ncn(C3CCCC3)c2n1 Chemical compound N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNCc2ccc(Cl)cc2)c2ncn(C3CCCC3)c2n1 OOIOAGNTKVNFIT-MXVIHJGJSA-N 0.000 description 1
- HLSIAYKWGBZTMY-WGSAOQKQSA-N N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNCc2ccc(OC(F)(F)F)cc2)c2ncn(C3CCCC3)c2n1 Chemical compound N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNCc2ccc(OC(F)(F)F)cc2)c2ncn(C3CCCC3)c2n1 HLSIAYKWGBZTMY-WGSAOQKQSA-N 0.000 description 1
- RBIFEVOTZUYWNH-JHJOSGQCSA-N N[C@H]1CC[C@@H](CC1)Nc1nc(NCc2cccc(I)c2)c2ncn(C3CCSC3)c2n1 Chemical compound N[C@H]1CC[C@@H](CC1)Nc1nc(NCc2cccc(I)c2)c2ncn(C3CCSC3)c2n1 RBIFEVOTZUYWNH-JHJOSGQCSA-N 0.000 description 1
- CCNHOYGHAZMVHV-WKILWMFISA-N N[C@H]1CC[C@@H](CC1)Nc1nc(NS(=O)(=O)c2ccc(Br)cc2)c2ncn(C3CCCC3)c2n1 Chemical compound N[C@H]1CC[C@@H](CC1)Nc1nc(NS(=O)(=O)c2ccc(Br)cc2)c2ncn(C3CCCC3)c2n1 CCNHOYGHAZMVHV-WKILWMFISA-N 0.000 description 1
- PWKCQUTXTGYNIS-JCNLHEQBSA-N N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccc(N)cc2)c2ncn(C3CCCC3)c2n1 Chemical compound N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccc(N)cc2)c2ncn(C3CCCC3)c2n1 PWKCQUTXTGYNIS-JCNLHEQBSA-N 0.000 description 1
- LTOWSRPDDLEADX-CCNKZBJGSA-N N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccc(OC(F)(F)F)cc2)c2ncn(C3CCSC3)c2n1 Chemical compound N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccc(OC(F)(F)F)cc2)c2ncn(C3CCSC3)c2n1 LTOWSRPDDLEADX-CCNKZBJGSA-N 0.000 description 1
- XKJIOTNYPMAMIE-WKILWMFISA-N N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2cccc(c2)C(O)=O)c2ncn(C3CCCC3)c2n1 Chemical compound N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2cccc(c2)C(O)=O)c2ncn(C3CCCC3)c2n1 XKJIOTNYPMAMIE-WKILWMFISA-N 0.000 description 1
- 229910021204 NaH2 PO4 Inorganic materials 0.000 description 1
- NXAAEQRIHIAVTL-LYRYQWTGSA-N OC(=O)[C@@H](O)[C@@H](O)C(O)=O.N1=C(N[C@@H]2CC[C@@H](N)CC2)N=C2N(C(CC)CC)C=NC2=C1NCC1=CC=CC=C1 Chemical compound OC(=O)[C@@H](O)[C@@H](O)C(O)=O.N1=C(N[C@@H]2CC[C@@H](N)CC2)N=C2N(C(CC)CC)C=NC2=C1NCC1=CC=CC=C1 NXAAEQRIHIAVTL-LYRYQWTGSA-N 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 229930012538 Paclitaxel Natural products 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- 101100273808 Xenopus laevis cdk1-b gene Proteins 0.000 description 1
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical compound C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 125000004423 acyloxy group Chemical group 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- BIIVYFLTOXDAOV-YVEFUNNKSA-N alvocidib Chemical compound O[C@@H]1CN(C)CC[C@@H]1C1=C(O)C=C(O)C2=C1OC(C=1C(=CC=CC=1)Cl)=CC2=O BIIVYFLTOXDAOV-YVEFUNNKSA-N 0.000 description 1
- 229950010817 alvocidib Drugs 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- MXMOTZIXVICDSD-UHFFFAOYSA-N anisoyl chloride Chemical compound COC1=CC=C(C(Cl)=O)C=C1 MXMOTZIXVICDSD-UHFFFAOYSA-N 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000008135 aqueous vehicle Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 230000003376 axonal effect Effects 0.000 description 1
- UDSRUCAJZSIRHZ-UHFFFAOYSA-N benzamide dihydrochloride Chemical compound Cl.Cl.NC(=O)C1=CC=CC=C1.NC(=O)C1=CC=CC=C1 UDSRUCAJZSIRHZ-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- KLQNJBAFEFFWQZ-UHFFFAOYSA-N benzoic acid;dihydrochloride Chemical compound Cl.Cl.OC(=O)C1=CC=CC=C1 KLQNJBAFEFFWQZ-UHFFFAOYSA-N 0.000 description 1
- JXHYCCGOZUGBFD-UHFFFAOYSA-N benzoic acid;hydrochloride Chemical compound Cl.OC(=O)C1=CC=CC=C1 JXHYCCGOZUGBFD-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 1
- 229910010277 boron hydride Inorganic materials 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- BMRWNKZVCUKKSR-UHFFFAOYSA-N butane-1,2-diol Chemical compound CCC(O)CO BMRWNKZVCUKKSR-UHFFFAOYSA-N 0.000 description 1
- DKHXJHOPUWNXSG-UHFFFAOYSA-N butyl 2-[4-[(2-chloro-9-cyclopentylpurin-6-yl)amino]phenyl]acetate Chemical compound C1=CC(CC(=O)OCCCC)=CC=C1NC1=NC(Cl)=NC2=C1N=CN2C1CCCC1 DKHXJHOPUWNXSG-UHFFFAOYSA-N 0.000 description 1
- 229930188620 butyrolactone Natural products 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 101150073031 cdk2 gene Proteins 0.000 description 1
- 101150059448 cdk7 gene Proteins 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
- 229960004316 cisplatin Drugs 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 229920001577 copolymer Chemical compound 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000006352 cycloaddition reaction Methods 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- NZNMSOFKMUBTKW-UHFFFAOYSA-M cyclohexanecarboxylate Chemical compound [O-]C(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-M 0.000 description 1
- 150000001934 cyclohexanes Chemical class 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- GVVOANLKCBPVIR-UHFFFAOYSA-N diethyl 5-[(2-chloro-9-cyclopentylpurin-6-yl)amino]benzene-1,3-dicarboxylate Chemical compound CCOC(=O)C1=CC(C(=O)OCC)=CC(NC=2C=3N=CN(C=3N=C(Cl)N=2)C2CCCC2)=C1 GVVOANLKCBPVIR-UHFFFAOYSA-N 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- AFAXGSQYZLGZPG-UHFFFAOYSA-N ethanedisulfonic acid Chemical compound OS(=O)(=O)CCS(O)(=O)=O AFAXGSQYZLGZPG-UHFFFAOYSA-N 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- LWLRAGQEMZOCHS-UHFFFAOYSA-N ethyl 2-[3-amino-5-(2-ethoxy-2-oxoethyl)phenyl]acetate Chemical compound CCOC(=O)CC1=CC(N)=CC(CC(=O)OCC)=C1 LWLRAGQEMZOCHS-UHFFFAOYSA-N 0.000 description 1
- OUXDYJUOWSJGFZ-UHFFFAOYSA-N ethyl 4-[(2-chloro-9-pentan-3-ylpurin-6-yl)amino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC1=NC(Cl)=NC2=C1N=CN2C(CC)CC OUXDYJUOWSJGFZ-UHFFFAOYSA-N 0.000 description 1
- GADPHXAWEODQPA-UHFFFAOYSA-N ethyl 4-[[2-chloro-9-(thiolan-3-yl)purin-6-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC1=NC(Cl)=NC2=C1N=CN2C1CSCC1 GADPHXAWEODQPA-UHFFFAOYSA-N 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-N formic acid Substances OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- LELOWRISYMNNSU-UHFFFAOYSA-N hydrogen cyanide Chemical class N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 1
- BNSOYWDFFBDEFB-UHFFFAOYSA-L hydroxy-(hydroxy(dioxo)chromio)oxy-dioxochromium;pyridine Chemical compound C1=CC=NC=C1.O[Cr](=O)(=O)O[Cr](O)(=O)=O BNSOYWDFFBDEFB-UHFFFAOYSA-L 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- FEWJPZIEWOKRBE-XIXRPRMCSA-L meso-tartrate(2-) Chemical compound [O-]C(=O)[C@@H](O)[C@@H](O)C([O-])=O FEWJPZIEWOKRBE-XIXRPRMCSA-L 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- OPUAWDUYWRUIIL-UHFFFAOYSA-N methanedisulfonic acid Chemical compound OS(=O)(=O)CS(O)(=O)=O OPUAWDUYWRUIIL-UHFFFAOYSA-N 0.000 description 1
- 229940087646 methanolamine Drugs 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- HUNUAFNLLYVTQD-UHFFFAOYSA-N methyl 2-chlorosulfonylbenzoate Chemical compound COC(=O)C1=CC=CC=C1S(Cl)(=O)=O HUNUAFNLLYVTQD-UHFFFAOYSA-N 0.000 description 1
- OWBKDJSKHXGOJY-UHFFFAOYSA-N methyl 3-(aminomethyl)benzoate Chemical compound COC(=O)C1=CC=CC(CN)=C1 OWBKDJSKHXGOJY-UHFFFAOYSA-N 0.000 description 1
- FEIOASZZURHTHB-UHFFFAOYSA-N methyl 4-formylbenzoate Chemical compound COC(=O)C1=CC=C(C=O)C=C1 FEIOASZZURHTHB-UHFFFAOYSA-N 0.000 description 1
- 125000004092 methylthiomethyl group Chemical group [H]C([H])([H])SC([H])([H])* 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- XSCIECAJYJCLQM-UHFFFAOYSA-N n'-(2-chloro-9-cyclopentylpurin-6-yl)-3-(trifluoromethyl)benzenesulfonohydrazide Chemical compound FC(F)(F)C1=CC=CC(S(=O)(=O)NNC=2C=3N=CN(C=3N=C(Cl)N=2)C2CCCC2)=C1 XSCIECAJYJCLQM-UHFFFAOYSA-N 0.000 description 1
- ANLHKJJEYLJDKT-UHFFFAOYSA-N n'-(2-chloro-9-cyclopentylpurin-6-yl)-4-ethoxybenzenesulfonohydrazide Chemical compound C1=CC(OCC)=CC=C1S(=O)(=O)NNC1=NC(Cl)=NC2=C1N=CN2C1CCCC1 ANLHKJJEYLJDKT-UHFFFAOYSA-N 0.000 description 1
- VEHSPYSPEQBWTK-UHFFFAOYSA-N n'-(2-chloro-9-cyclopentylpurin-6-yl)-4-methylbenzenesulfonohydrazide Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NNC1=NC(Cl)=NC2=C1N=CN2C1CCCC1 VEHSPYSPEQBWTK-UHFFFAOYSA-N 0.000 description 1
- DWYCPFNJODGTTM-UHFFFAOYSA-N n'-(2-chloro-9-cyclopentylpurin-6-yl)-n-[(3,4,5-trimethoxyphenyl)methyl]ethane-1,2-diamine Chemical compound COC1=C(OC)C(OC)=CC(CNCCNC=2C=3N=CN(C=3N=C(Cl)N=2)C2CCCC2)=C1 DWYCPFNJODGTTM-UHFFFAOYSA-N 0.000 description 1
- YZEJTLHDSIWFME-UHFFFAOYSA-N n'-(2-chloro-9-cyclopentylpurin-6-yl)-n-[(3,4-dichlorophenyl)methyl]ethane-1,2-diamine Chemical compound C=12N=CN(C3CCCC3)C2=NC(Cl)=NC=1NCCNCC1=CC=C(Cl)C(Cl)=C1 YZEJTLHDSIWFME-UHFFFAOYSA-N 0.000 description 1
- YGOORGQQYROFSM-UHFFFAOYSA-N n'-(2-chloro-9-cyclopentylpurin-6-yl)-n-[(3,5-dichlorophenyl)methyl]ethane-1,2-diamine Chemical compound ClC1=CC(Cl)=CC(CNCCNC=2C=3N=CN(C=3N=C(Cl)N=2)C2CCCC2)=C1 YGOORGQQYROFSM-UHFFFAOYSA-N 0.000 description 1
- QNTZFOGPMMLQCX-UHFFFAOYSA-N n'-(2-chloro-9-cyclopentylpurin-6-yl)-n-[(3-chlorophenyl)methyl]ethane-1,2-diamine Chemical compound ClC1=CC=CC(CNCCNC=2C=3N=CN(C=3N=C(Cl)N=2)C2CCCC2)=C1 QNTZFOGPMMLQCX-UHFFFAOYSA-N 0.000 description 1
- RTXZWORQKAJOFL-UHFFFAOYSA-N n'-(2-chloro-9-cyclopentylpurin-6-yl)-n-[(4-chlorophenyl)methyl]ethane-1,2-diamine Chemical compound C1=CC(Cl)=CC=C1CNCCNC1=NC(Cl)=NC2=C1N=CN2C1CCCC1 RTXZWORQKAJOFL-UHFFFAOYSA-N 0.000 description 1
- ZLOODNNWRVFGQY-UHFFFAOYSA-N n'-(2-chloro-9-cyclopentylpurin-6-yl)-n-[(4-fluorophenyl)methyl]ethane-1,2-diamine Chemical compound C1=CC(F)=CC=C1CNCCNC1=NC(Cl)=NC2=C1N=CN2C1CCCC1 ZLOODNNWRVFGQY-UHFFFAOYSA-N 0.000 description 1
- JDXQPCJUSGUHDD-UHFFFAOYSA-N n'-(2-chloro-9-cyclopentylpurin-6-yl)-n-[(4-methoxyphenyl)methyl]ethane-1,2-diamine Chemical compound C1=CC(OC)=CC=C1CNCCNC1=NC(Cl)=NC2=C1N=CN2C1CCCC1 JDXQPCJUSGUHDD-UHFFFAOYSA-N 0.000 description 1
- KJYTXNRYGIATAA-UHFFFAOYSA-N n'-(2-chloro-9-cyclopentylpurin-6-yl)-n-[(7-methoxy-1,3-benzodioxol-5-yl)methyl]ethane-1,2-diamine Chemical compound C=1C=2OCOC=2C(OC)=CC=1CNCCNC(C=1N=C2)=NC(Cl)=NC=1N2C1CCCC1 KJYTXNRYGIATAA-UHFFFAOYSA-N 0.000 description 1
- FGVGDJILZZBXQU-UHFFFAOYSA-N n'-(2-chloro-9-cyclopentylpurin-6-yl)-n-[[4-(trifluoromethoxy)phenyl]methyl]ethane-1,2-diamine Chemical compound C1=CC(OC(F)(F)F)=CC=C1CNCCNC1=NC(Cl)=NC2=C1N=CN2C1CCCC1 FGVGDJILZZBXQU-UHFFFAOYSA-N 0.000 description 1
- YOKBECNMVDUBSS-UHFFFAOYSA-N n'-(2-chloro-9-cyclopentylpurin-6-yl)-n-[[4-(trifluoromethyl)phenyl]methyl]ethane-1,2-diamine Chemical compound C1=CC(C(F)(F)F)=CC=C1CNCCNC1=NC(Cl)=NC2=C1N=CN2C1CCCC1 YOKBECNMVDUBSS-UHFFFAOYSA-N 0.000 description 1
- WFAKXKVHHXGZIJ-UHFFFAOYSA-N n'-(2-chloro-9-cyclopentylpurin-6-yl)benzenesulfonohydrazide Chemical compound C=12N=CN(C3CCCC3)C2=NC(Cl)=NC=1NNS(=O)(=O)C1=CC=CC=C1 WFAKXKVHHXGZIJ-UHFFFAOYSA-N 0.000 description 1
- RHOAHBLVHCUZBB-UHFFFAOYSA-N n'-(2-chloro-9-cyclopentylpurin-6-yl)ethane-1,2-diamine Chemical compound C1=NC=2C(NCCN)=NC(Cl)=NC=2N1C1CCCC1 RHOAHBLVHCUZBB-UHFFFAOYSA-N 0.000 description 1
- WEHQXUPZGVIXLS-UHFFFAOYSA-N n'-(2-chloro-9-cyclopentylpurin-6-yl)pyridine-3-sulfonohydrazide Chemical compound C=12N=CN(C3CCCC3)C2=NC(Cl)=NC=1NNS(=O)(=O)C1=CC=CN=C1 WEHQXUPZGVIXLS-UHFFFAOYSA-N 0.000 description 1
- BFLKQFRFSGCWRN-UHFFFAOYSA-N n'-benzhydryl-n-(2-chloro-9-cyclopentylpurin-6-yl)ethane-1,2-diamine Chemical compound C=12N=CN(C3CCCC3)C2=NC(Cl)=NC=1NCCNC(C=1C=CC=CC=1)C1=CC=CC=C1 BFLKQFRFSGCWRN-UHFFFAOYSA-N 0.000 description 1
- PAMCRRDMORMCSM-UHFFFAOYSA-N n-(trifluoromethyl)benzamide Chemical compound FC(F)(F)NC(=O)C1=CC=CC=C1 PAMCRRDMORMCSM-UHFFFAOYSA-N 0.000 description 1
- SLDBXMFBOFIMAL-UHFFFAOYSA-N n-[2-[(2-chloro-9-cyclopentylpurin-6-yl)amino]ethyl]-1,1,1-trifluoromethanesulfonamide Chemical compound C1=NC=2C(NCCNS(=O)(=O)C(F)(F)F)=NC(Cl)=NC=2N1C1CCCC1 SLDBXMFBOFIMAL-UHFFFAOYSA-N 0.000 description 1
- WPSNSOBUGDVDBA-UHFFFAOYSA-N n-[2-[(2-chloro-9-cyclopentylpurin-6-yl)amino]ethyl]-3,4-dimethoxybenzamide Chemical compound C1=C(OC)C(OC)=CC=C1C(=O)NCCNC1=NC(Cl)=NC2=C1N=CN2C1CCCC1 WPSNSOBUGDVDBA-UHFFFAOYSA-N 0.000 description 1
- ZHBMHDXJHHBCDK-UHFFFAOYSA-N n-[2-[(2-chloro-9-cyclopentylpurin-6-yl)amino]ethyl]-3-(trifluoromethoxy)benzamide Chemical compound FC(F)(F)OC1=CC=CC(C(=O)NCCNC=2C=3N=CN(C=3N=C(Cl)N=2)C2CCCC2)=C1 ZHBMHDXJHHBCDK-UHFFFAOYSA-N 0.000 description 1
- RMUNRGCSZKQLLN-UHFFFAOYSA-N n-[2-[(2-chloro-9-cyclopentylpurin-6-yl)amino]ethyl]-3-(trifluoromethyl)benzamide Chemical compound FC(F)(F)C1=CC=CC(C(=O)NCCNC=2C=3N=CN(C=3N=C(Cl)N=2)C2CCCC2)=C1 RMUNRGCSZKQLLN-UHFFFAOYSA-N 0.000 description 1
- AVVYNZKXRMXYBU-UHFFFAOYSA-N n-[2-[(2-chloro-9-cyclopentylpurin-6-yl)amino]ethyl]-4-(trifluoromethyl)benzamide Chemical compound C1=CC(C(F)(F)F)=CC=C1C(=O)NCCNC1=NC(Cl)=NC2=C1N=CN2C1CCCC1 AVVYNZKXRMXYBU-UHFFFAOYSA-N 0.000 description 1
- GTVCBPDKPLBEMM-UHFFFAOYSA-N n-[2-[(2-chloro-9-cyclopentylpurin-6-yl)amino]ethyl]-4-fluorobenzamide Chemical compound C1=CC(F)=CC=C1C(=O)NCCNC1=NC(Cl)=NC2=C1N=CN2C1CCCC1 GTVCBPDKPLBEMM-UHFFFAOYSA-N 0.000 description 1
- GIAFFJATAKDHTN-UHFFFAOYSA-N n-[2-[(2-chloro-9-cyclopentylpurin-6-yl)amino]ethyl]-4-fluorobenzenesulfonamide Chemical compound C1=CC(F)=CC=C1S(=O)(=O)NCCNC1=NC(Cl)=NC2=C1N=CN2C1CCCC1 GIAFFJATAKDHTN-UHFFFAOYSA-N 0.000 description 1
- JAFOXORPADOCKD-UHFFFAOYSA-N n-[2-[(2-chloro-9-cyclopentylpurin-6-yl)amino]ethyl]-4-methoxybenzamide Chemical compound C1=CC(OC)=CC=C1C(=O)NCCNC1=NC(Cl)=NC2=C1N=CN2C1CCCC1 JAFOXORPADOCKD-UHFFFAOYSA-N 0.000 description 1
- IZQYPUHUYMUXSH-UHFFFAOYSA-N n-[2-[(2-chloro-9-cyclopentylpurin-6-yl)amino]ethyl]-4-methoxybenzenesulfonamide Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)NCCNC1=NC(Cl)=NC2=C1N=CN2C1CCCC1 IZQYPUHUYMUXSH-UHFFFAOYSA-N 0.000 description 1
- UBAVQGMWROQDTR-UHFFFAOYSA-N n-[2-[(2-chloro-9-cyclopentylpurin-6-yl)amino]ethyl]-4-methylbenzenesulfonamide Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NCCNC1=NC(Cl)=NC2=C1N=CN2C1CCCC1 UBAVQGMWROQDTR-UHFFFAOYSA-N 0.000 description 1
- MINJBLHUGLZYOG-UHFFFAOYSA-N n-[2-[(2-chloro-9-cyclopentylpurin-6-yl)amino]ethyl]-4-methylsulfanylbenzamide Chemical compound C1=CC(SC)=CC=C1C(=O)NCCNC1=NC(Cl)=NC2=C1N=CN2C1CCCC1 MINJBLHUGLZYOG-UHFFFAOYSA-N 0.000 description 1
- XFALHLCWYBNJOR-UHFFFAOYSA-N n-[2-[(2-chloro-9-cyclopentylpurin-6-yl)amino]ethyl]propane-2-sulfonamide Chemical compound C1=NC=2C(NCCNS(=O)(=O)C(C)C)=NC(Cl)=NC=2N1C1CCCC1 XFALHLCWYBNJOR-UHFFFAOYSA-N 0.000 description 1
- UDUOCRUXMANDCI-UHFFFAOYSA-N n-benzyl-2-chloro-9-(oxolan-3-yl)purin-6-amine Chemical compound C=12N=CN(C3COCC3)C2=NC(Cl)=NC=1NCC1=CC=CC=C1 UDUOCRUXMANDCI-UHFFFAOYSA-N 0.000 description 1
- PCEUCOTXPALORE-UHFFFAOYSA-N n-benzyl-2-chloro-9-(thiolan-3-yl)purin-6-amine Chemical compound C=12N=CN(C3CSCC3)C2=NC(Cl)=NC=1NCC1=CC=CC=C1 PCEUCOTXPALORE-UHFFFAOYSA-N 0.000 description 1
- APURIMWVMQIOPD-UHFFFAOYSA-N n-benzyl-2-chloro-9-cyclopentylpurin-6-amine Chemical compound C=12N=CN(C3CCCC3)C2=NC(Cl)=NC=1NCC1=CC=CC=C1 APURIMWVMQIOPD-UHFFFAOYSA-N 0.000 description 1
- IVWAKBQIWKSQOL-UHFFFAOYSA-N n-benzyl-2-chloro-9-pentan-3-ylpurin-6-amine Chemical compound N1=C(Cl)N=C2N(C(CC)CC)C=NC2=C1NCC1=CC=CC=C1 IVWAKBQIWKSQOL-UHFFFAOYSA-N 0.000 description 1
- HFRGFRFJCWEUJH-UHFFFAOYSA-N n-benzyl-9-butan-2-yl-2-chloropurin-6-amine Chemical compound N1=C(Cl)N=C2N(C(C)CC)C=NC2=C1NCC1=CC=CC=C1 HFRGFRFJCWEUJH-UHFFFAOYSA-N 0.000 description 1
- RMDSNTGPWAIXSF-UHFFFAOYSA-N n-benzyl-n'-(2-chloro-9-cyclopentylpurin-6-yl)ethane-1,2-diamine Chemical compound C=12N=CN(C3CCCC3)C2=NC(Cl)=NC=1NCCNCC1=CC=CC=C1 RMDSNTGPWAIXSF-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 229910000069 nitrogen hydride Inorganic materials 0.000 description 1
- 239000002687 nonaqueous vehicle Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- BHAAPTBBJKJZER-UHFFFAOYSA-N p-anisidine Chemical compound COC1=CC=C(N)C=C1 BHAAPTBBJKJZER-UHFFFAOYSA-N 0.000 description 1
- 229960001592 paclitaxel Drugs 0.000 description 1
- SEVSMVUOKAMPDO-UHFFFAOYSA-N para-Acetoxybenzaldehyde Natural products CC(=O)OC1=CC=C(C=O)C=C1 SEVSMVUOKAMPDO-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- RUOPINZRYMFPBF-UHFFFAOYSA-N pentane-1,3-diol Chemical compound CCC(O)CCO RUOPINZRYMFPBF-UHFFFAOYSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- KCXFHTAICRTXLI-UHFFFAOYSA-N propane-1-sulfonic acid Chemical compound CCCS(O)(=O)=O KCXFHTAICRTXLI-UHFFFAOYSA-N 0.000 description 1
- DRINJBFRTLBHNF-UHFFFAOYSA-N propane-2-sulfonyl chloride Chemical compound CC(C)S(Cl)(=O)=O DRINJBFRTLBHNF-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000001012 protector Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 125000004542 purin-6-yl group Chemical group N1=CN=C2N=CNC2=C1* 0.000 description 1
- NKFLEFWUYAUDJV-UHFFFAOYSA-N pyridine-3-sulfonamide Chemical compound NS(=O)(=O)C1=CC=CN=C1 NKFLEFWUYAUDJV-UHFFFAOYSA-N 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 1
- JNMRHUJNCSQMMB-UHFFFAOYSA-N sulfathiazole Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CS1 JNMRHUJNCSQMMB-UHFFFAOYSA-N 0.000 description 1
- 125000001174 sulfone group Chemical group 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- WZHRJGWXUCLILI-UHFFFAOYSA-N sulfonylcarbamic acid Chemical compound OC(=O)N=S(=O)=O WZHRJGWXUCLILI-UHFFFAOYSA-N 0.000 description 1
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
- 125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- BJYXNFYVCZIXQC-UHFFFAOYSA-N thiolan-3-ol Chemical compound OC1CCSC1 BJYXNFYVCZIXQC-UHFFFAOYSA-N 0.000 description 1
- LMYRWZFENFIFIT-UHFFFAOYSA-N toluene-4-sulfonamide Chemical compound CC1=CC=C(S(N)(=O)=O)C=C1 LMYRWZFENFIFIT-UHFFFAOYSA-N 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- JKVRTUCVPZTEQZ-UHFFFAOYSA-N tributyltin azide Chemical compound CCCC[Sn](CCCC)(CCCC)N=[N+]=[N-] JKVRTUCVPZTEQZ-UHFFFAOYSA-N 0.000 description 1
- ZMCBYSBVJIMENC-UHFFFAOYSA-N tricaine Chemical compound CCOC(=O)C1=CC=CC(N)=C1 ZMCBYSBVJIMENC-UHFFFAOYSA-N 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/24—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one nitrogen and one sulfur atom
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hospice & Palliative Care (AREA)
- Communicable Diseases (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9906456A FR2793794B1 (fr) | 1999-05-21 | 1999-05-21 | Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1183256E true PT1183256E (pt) | 2007-11-13 |
Family
ID=9545846
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT00929625T PT1183256E (pt) | 1999-05-21 | 2000-05-18 | Derivados de purina, processo de preparação e composições farmacêuticas que os contêm |
Country Status (33)
| Country | Link |
|---|---|
| US (2) | US7122669B1 (OSRAM) |
| EP (1) | EP1183256B1 (OSRAM) |
| JP (1) | JP2003500407A (OSRAM) |
| KR (1) | KR100707895B1 (OSRAM) |
| CN (1) | CN1298719C (OSRAM) |
| AP (1) | AP1477A (OSRAM) |
| AR (1) | AR035317A1 (OSRAM) |
| AT (1) | ATE370951T1 (OSRAM) |
| AU (1) | AU4764500A (OSRAM) |
| BR (1) | BR0011282A (OSRAM) |
| CA (1) | CA2374714A1 (OSRAM) |
| CZ (1) | CZ20014163A3 (OSRAM) |
| DE (1) | DE60036102T2 (OSRAM) |
| DK (1) | DK1183256T3 (OSRAM) |
| DZ (1) | DZ3166A1 (OSRAM) |
| EA (1) | EA005072B1 (OSRAM) |
| ES (1) | ES2290033T3 (OSRAM) |
| FR (1) | FR2793794B1 (OSRAM) |
| HU (1) | HUP0201649A3 (OSRAM) |
| IL (1) | IL146441A0 (OSRAM) |
| MA (1) | MA26791A1 (OSRAM) |
| MX (1) | MXPA01011834A (OSRAM) |
| NO (1) | NO20015659L (OSRAM) |
| NZ (1) | NZ515556A (OSRAM) |
| PL (1) | PL352293A1 (OSRAM) |
| PT (1) | PT1183256E (OSRAM) |
| SK (1) | SK16722001A3 (OSRAM) |
| TR (1) | TR200103349T2 (OSRAM) |
| TW (1) | TWI284130B (OSRAM) |
| UA (1) | UA68441C2 (OSRAM) |
| WO (1) | WO2000071543A1 (OSRAM) |
| YU (1) | YU86601A (OSRAM) |
| ZA (1) | ZA200109602B (OSRAM) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6479487B1 (en) * | 1998-02-26 | 2002-11-12 | Aventis Pharmaceuticals Inc. | 6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines |
| US6413974B1 (en) * | 1998-02-26 | 2002-07-02 | Aventis Pharmaceuticals Inc. | 6,9,-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines |
| US6969720B2 (en) | 1999-03-17 | 2005-11-29 | Amr Technology, Inc. | Biaryl substituted purine derivatives as potent antiproliferative agents |
| US6861524B2 (en) * | 2000-10-31 | 2005-03-01 | Aventis Pharmaceuticals Inc. | Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents |
| DE60138140D1 (de) * | 2000-10-31 | 2009-05-07 | Aventis Pharma Inc | Acyl- und sulfonylderivative 6,9-disubstitutierter 2-(trans-1,4-diaminocyclohexyl)-purine und ihre verwendung als antiproliferative mittel |
| FR2818642B1 (fr) * | 2000-12-26 | 2005-07-15 | Hoechst Marion Roussel Inc | Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilistion |
| US6667311B2 (en) * | 2001-09-11 | 2003-12-23 | Albany Molecular Research, Inc. | Nitrogen substituted biaryl purine derivatives as potent antiproliferative agents |
| US6812232B2 (en) | 2001-09-11 | 2004-11-02 | Amr Technology, Inc. | Heterocycle substituted purine derivatives as potent antiproliferative agents |
| EP1578722A4 (en) * | 2001-10-12 | 2006-09-06 | Irm Llc | KINASEINHIBITOR SCAFFOLD AND METHOD FOR THE PRODUCTION THEREOF |
| JP4664205B2 (ja) * | 2002-10-15 | 2011-04-06 | アイアールエム エルエルシー | 骨形成を誘導する組成物および方法 |
| FR2851248B1 (fr) * | 2003-02-18 | 2005-04-08 | Aventis Pharma Sa | Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation |
| EP1682150B1 (en) * | 2003-11-10 | 2012-12-26 | The Scripps Research Institute | Compositions and methods for inducing cell dedifferentiation |
| AU2005231440B9 (en) * | 2004-04-02 | 2012-02-23 | Dogwood Pharmaceuticals, Inc. | Selective antagonists of A2A adenosine receptors |
| CZ302122B6 (cs) * | 2009-01-28 | 2010-10-20 | Univerzita Palackého v Olomouci | Substituované deriváty 6-(2-aminobenzylamino)purinu, jejich použití jako léciva a prípravky tyto slouceniny obsahující |
| WO2012142029A2 (en) | 2011-04-10 | 2012-10-18 | Florida A&M University | Serms for the treatment of estrogen receptor-mediated disorders |
| WO2015162518A1 (en) | 2014-04-25 | 2015-10-29 | Pfizer Inc. | Heteroaromatic compounds and their use as dopamine d1 ligands |
| WO2018064545A1 (en) * | 2016-09-30 | 2018-04-05 | Sri International | Dual clk/cdk1 inhibitors for cancer treatment |
| CZ308029B6 (cs) | 2017-03-20 | 2019-11-06 | Univerzita PalackĂ©ho v Olomouci | 2,6-Disubstituované-9-cyklopentyl-9H-puriny, jejich použití jako léčiva a farmaceutické přípravky |
| US20240247001A1 (en) | 2022-12-16 | 2024-07-25 | Astrazeneca Ab | 2,6,9-trisubstituted purines |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4008858A1 (de) * | 1990-03-20 | 1991-09-26 | Hoechst Ag | Substituierte purine, verfahren zu ihrer hertellung sowie ihre verwendung als antivirale mittel |
| DE69231194T2 (de) * | 1991-12-05 | 2001-02-15 | Texas Instruments Inc., Dallas | Verfahren zur Verbesserung eines Videosignals |
| CA2084222C (en) * | 1991-12-06 | 2004-04-06 | David R. Borcherding | Novel trans cyclopentanyl purine analogs useful as immunosuppressants |
| US7091346B1 (en) * | 1995-11-01 | 2006-08-15 | Novartis Ag | Purine derivatives and processes for their preparation |
| FR2741881B1 (fr) * | 1995-12-01 | 1999-07-30 | Centre Nat Rech Scient | Nouveaux derives de purine possedant notamment des prorietes anti-proliferatives et leurs applications biologiques |
| US6790958B2 (en) * | 1996-08-02 | 2004-09-14 | Robert T. Lum | Purine inhibitors of cyclin dependent kinase 2 & IKBA |
| US5866702A (en) * | 1996-08-02 | 1999-02-02 | Cv Therapeutics, Incorporation | Purine inhibitors of cyclin dependent kinase 2 |
| AU4920397A (en) * | 1996-10-11 | 1998-05-11 | Chiron Corporation | Purine inhibitors of glycogen synthase kinase 3 (gsk3) |
| CA2297967A1 (en) * | 1997-08-07 | 1999-02-18 | The Regents Of The University Of California | Purine inhibitor of protein kinases, g proteins and polymerases |
| US6413974B1 (en) * | 1998-02-26 | 2002-07-02 | Aventis Pharmaceuticals Inc. | 6,9,-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines |
| US6479487B1 (en) * | 1998-02-26 | 2002-11-12 | Aventis Pharmaceuticals Inc. | 6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines |
| GB9903762D0 (en) * | 1999-02-18 | 1999-04-14 | Novartis Ag | Organic compounds |
| FR2818642B1 (fr) * | 2000-12-26 | 2005-07-15 | Hoechst Marion Roussel Inc | Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilistion |
-
1999
- 1999-05-21 FR FR9906456A patent/FR2793794B1/fr not_active Expired - Fee Related
-
2000
- 2000-05-09 TW TW089108817A patent/TWI284130B/zh not_active IP Right Cessation
- 2000-05-18 EP EP00929625A patent/EP1183256B1/fr not_active Expired - Lifetime
- 2000-05-18 PT PT00929625T patent/PT1183256E/pt unknown
- 2000-05-18 UA UA2001128864A patent/UA68441C2/uk unknown
- 2000-05-18 CN CNB008106509A patent/CN1298719C/zh not_active Expired - Fee Related
- 2000-05-18 AT AT00929625T patent/ATE370951T1/de not_active IP Right Cessation
- 2000-05-18 MX MXPA01011834A patent/MXPA01011834A/es active IP Right Grant
- 2000-05-18 TR TR2001/03349T patent/TR200103349T2/xx unknown
- 2000-05-18 IL IL14644100A patent/IL146441A0/xx unknown
- 2000-05-18 YU YU86601A patent/YU86601A/sh unknown
- 2000-05-18 HU HU0201649A patent/HUP0201649A3/hu unknown
- 2000-05-18 KR KR1020017014800A patent/KR100707895B1/ko not_active Expired - Fee Related
- 2000-05-18 PL PL00352293A patent/PL352293A1/xx not_active Application Discontinuation
- 2000-05-18 ES ES00929625T patent/ES2290033T3/es not_active Expired - Lifetime
- 2000-05-18 CZ CZ20014163A patent/CZ20014163A3/cs unknown
- 2000-05-18 CA CA002374714A patent/CA2374714A1/fr not_active Abandoned
- 2000-05-18 DZ DZ003166A patent/DZ3166A1/xx active
- 2000-05-18 DE DE60036102T patent/DE60036102T2/de not_active Expired - Fee Related
- 2000-05-18 WO PCT/FR2000/001335 patent/WO2000071543A1/fr not_active Ceased
- 2000-05-18 NZ NZ515556A patent/NZ515556A/en unknown
- 2000-05-18 AP APAP/P/2001/002355A patent/AP1477A/en active
- 2000-05-18 AU AU47645/00A patent/AU4764500A/en not_active Abandoned
- 2000-05-18 EA EA200101224A patent/EA005072B1/ru not_active IP Right Cessation
- 2000-05-18 SK SK1672-2001A patent/SK16722001A3/sk unknown
- 2000-05-18 US US09/979,389 patent/US7122669B1/en not_active Expired - Fee Related
- 2000-05-18 BR BR0011282-8A patent/BR0011282A/pt not_active Application Discontinuation
- 2000-05-18 JP JP2000619799A patent/JP2003500407A/ja not_active Abandoned
- 2000-05-18 DK DK00929625T patent/DK1183256T3/da active
- 2000-05-19 AR ARP000102428A patent/AR035317A1/es not_active Application Discontinuation
-
2001
- 2001-11-15 MA MA26410A patent/MA26791A1/fr unknown
- 2001-11-20 NO NO20015659A patent/NO20015659L/no not_active Application Discontinuation
- 2001-11-21 ZA ZA200109602A patent/ZA200109602B/xx unknown
-
2004
- 2004-12-07 US US11/006,013 patent/US7208598B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1183256E (pt) | Derivados de purina, processo de preparação e composições farmacêuticas que os contêm | |
| ES2458596T3 (es) | Compuestos orgánicos | |
| ES2260036T3 (es) | Derivados de urea como inhibidores del receptor ccr-3. | |
| ES2392999T3 (es) | Bloqueadores de canales de sodio pirazinoilguanidina sustituida con fenilo que tienen actividad agonista beta | |
| ES2305317T3 (es) | Derivados de amida bifenilcarboxilico como inhibidores de quinasa p38. | |
| JP4084189B2 (ja) | 尿素の新誘導体、それらの製造方法、それらの薬剤としての使用、製薬組成物及び新規な用途 | |
| ES2215626T3 (es) | N-cianomethil amidas como inhibidores de proteasas. | |
| CA3074459A1 (en) | Inhibitors of egfr and/or her2 and methods of use | |
| CN116589459A (zh) | 凋亡诱导剂 | |
| TW201002327A (en) | Cytokine inhibitors | |
| TW406077B (en) | 7-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists | |
| HRP20030141A2 (en) | Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors | |
| DD277274A5 (de) | Verfahren zur herstellung von alkoxybenzonitrilderivaten | |
| EP0221511B1 (en) | 2-aminosulfonyl-6-nitrobenzoic esters or amides, process for their preparation and pharmaceutical compositions containing them | |
| EA023716B1 (ru) | Кристаллическая форма сукцината | |
| CN116854644A (zh) | 5-氨基-1-烷基-1h-1,2,3-三氮唑-4-甲酰胺类化合物及其制备和应用 | |
| US4647588A (en) | 2-(substituted sulfamyl)-6-nitrobenzoic acid amides and pharmaceutical compositions | |
| JP6736659B2 (ja) | 疼痛のための治療化合物及びその合成 | |
| US6875884B1 (en) | Urea derivatives as inhibitors for CCR-3 receptor | |
| CN109476605A (zh) | 具有抗肿瘤活性的苯并-n-羟基酰胺化合物 | |
| AU2006202270A1 (en) | Purine derivatives, preparation method and pharmaceutical compositions containing same | |
| KR20150042078A (ko) | N-(2,2’-이중치환-2h-크로멘-6-일)-n’,n”-이중치환-구아니딘 유도체를 포함하는 천식 또는 염증 질환의 예방 또는 치료용 약학적 조성물 | |
| JPS63183557A (ja) | 放射線療法の補助剤として有用な2−(置換スルフアミル)−6−ニトロ安息香酸類誘導体 | |
| BR112019021434B1 (pt) | Agentes indutores de apoptose, seus usos, e composição |